Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1050.Time spend outdoors in summer,44424,0.124106038408134,0.0272829208075703,0.0706315136252965,0.177580563190972,5.4081210443059e-06
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1060.Time spent outdoors in winter,38737,0.0378462885877963,0.0307317690544255,-0.0223879787588776,0.0980805559344703,0.218141996994612
EPHA2,Ephrin type-A receptor 2,Physical activities,X1070.Time spent watching television (TV),46738,0.238570480232146,0.027697466534437,0.18428344582465,0.292857514639643,7.30745558215468e-18
EPHA2,Ephrin type-A receptor 2,Physical activities,X1080.Time spent using computer,38768,-0.114397050283526,0.0277300867686686,-0.168748020350117,-0.0600460802169359,3.70900470450102e-05
EPHA2,Ephrin type-A receptor 2,Physical activities,X1090.Time spent driving,33587,-0.188079605457528,0.0306147754887639,-0.248084565415505,-0.128074645499551,8.16662694297081e-10
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1160.Sleep duration,49217,0.0796006534075498,0.0248492801374158,0.0308960643382149,0.128305242476885,0.00135930737600071
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,16435,0.00321605793164537,0.00794172656355964,-0.0123497261329315,0.0187818419962223,0.685514378291214
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,16435,0.00642834355971712,0.00770968434782703,-0.00868263776202385,0.0215393248814581,0.404405183905568
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,16435,0.0279132945557442,0.00882801758564128,0.0106103800878873,0.0452162090236012,0.0015702935148456
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,16435,0.0206654393845302,0.00905858024811206,0.00291062209823061,0.0384202566708299,0.0225427895488251
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,16435,0.0351029196175984,0.00916831317920583,0.017133025786355,0.0530728134488418,0.000129288831657749
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,16435,-0.00336172499860542,0.0194666176870979,-0.0415162956653173,0.0347928456681065,0.862895827999894
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,16435,0.0269849587480377,0.0200681050506428,-0.0123485271512223,0.0663184446472977,0.178750722648123
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,16435,0.0178417856520038,0.0138151069480886,-0.00923582396624979,0.0449193952702574,0.196559193207311
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,16435,0.0413752571526481,0.0101436236743784,0.0214937547508666,0.0612567595544297,4.54545170131798e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,16435,0.0196247092403565,0.00697497017636157,0.00595376769468785,0.0332956507860252,0.00490498233763549
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,16435,0.0201875428953064,0.01011298094595,0.000366100241244435,0.0400089855493684,0.0459285299908927
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,16435,0.0135547808766332,0.00567769064865561,0.0024265072052682,0.0246830545479982,0.0169803806664069
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,16435,0.00475102764194253,0.00732274146653246,-0.0096015456324611,0.0191036009163462,0.516473819340597
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,16435,0.0225394375924719,0.0108458701929721,0.00128153201424656,0.0437973431706972,0.0377102554903823
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,16435,0.0245890976020051,0.0102671815402932,0.0044654217830303,0.0447127734209798,0.016635043001933
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,16435,0.0264876583370135,0.0137814439812928,-0.000523971866320371,0.0534992885403473,0.0546255705877204
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,16435,0.0140257561571413,0.013099584271661,-0.0116494290153142,0.0397009413295969,0.284319005628156
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,16435,0.0130343519806428,0.00793779058926225,-0.00252371757431119,0.0285924215355968,0.100596103504997
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,16435,0.020446952774815,0.00753158095513937,0.00568505410274183,0.0352088514468882,0.00663793256818689
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,16435,0.0149656458142442,0.00939973423026244,-0.0034578332770702,0.0333891249055585,0.111373623512389
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120040.Fatigue severity over the past week,16445,0.207188649970416,0.0483619987451103,0.112399132429999,0.301978167510832,1.84506303312138e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,16445,0.194382786439772,0.0480068132300866,0.100289432508802,0.288476140370742,5.1658153889155e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,16446,0.103007655182199,0.0517737618758728,0.00153108190548867,0.20448422845891,0.0466545931165189
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120098.Mobility problems today,16454,0.427024750279368,0.0559580948500908,0.31734688437319,0.536702616185546,2.45380532587611e-14
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120099.Self-care problems today,16454,0.414733413528236,0.0840087250387323,0.25007631245232,0.579390514604151,8.01975154534998e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120100.Problems doing usual activities,16454,0.309806328340294,0.0533450929561137,0.205249946146311,0.414362710534277,6.45491435765242e-09
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120101.Pain or discomfort today,16454,0.198893165978919,0.0485728739516429,0.103690333033699,0.294095998924139,4.24668975988343e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120102.Anxiety or depression today,16454,0.199591084949007,0.0582902302771261,0.0853422336058399,0.313839936292174,0.000618363748820306
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120103.Scale to indicate how health is today,16401,-0.0130504684603915,0.00245752144655942,-0.017867210495648,-0.00823372642513507,1.10800955892477e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,16413,0.247877894034723,0.0586017294775578,0.13301850425871,0.362737283810736,2.35091798398616e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",16390,0.179917246209865,0.060484307990468,0.0613680025485479,0.298466489871183,0.00293788813901479
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",16425,0.0929999348454816,0.0481340997477139,-0.00134290066003766,0.187342770351001,0.0533642532909612
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,16424,0.187608561115159,0.0492439258152053,0.0910904665173567,0.284126655712962,0.00013959734033726
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,16431,0.325452625746062,0.063101837728953,0.201773023797314,0.44913222769481,2.53074588964312e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,16387,0.126640821403635,0.0637820879701821,0.00162792898207753,0.251653713825192,0.0471029367269439
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,16429,0.204356033156914,0.0633788781885792,0.0801334319072988,0.328578634406529,0.00126503504456012
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,16416,0.33045090918289,0.0902995319124907,0.153463826634409,0.507437991731372,0.000253502847826928
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,16343,0.376807934011974,0.124441635497283,0.132902328437299,0.620713539586648,0.00246571099039614
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11474,0.352226771258571,0.0638652336393146,0.227050913325514,0.477402629191628,3.56028033133357e-08
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,44535,0.203950967263004,0.0567882420497371,0.0926460128455194,0.315255921680489,0.000329223040750456
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,41562,0.0539279583267217,0.0362912148458882,-0.0172028227712192,0.125058739424663,0.137292444371561
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1289.Cooked vegetable intake,47815,-0.231264815971316,0.0257260803068457,-0.281687933372733,-0.180841698569898,2.57173196565474e-19
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46534,-0.203374266358985,0.0272527322876549,-0.256789621642789,-0.149958911075182,8.63548374647292e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1309.Fresh fruit intake,47693,-0.00878825229633865,0.0269921860252763,-0.0616929369058801,0.0441164323132028,0.744739751868327
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1319.Dried fruit intake,45072,-0.0843442653600648,0.0278989213575286,-0.139026151220821,-0.0296623794993087,0.00250250190013833
EPHA2,Ephrin type-A receptor 2,Health and medical history,X134.Number of self-reported cancers,49643,0.450044059565558,0.0444006743386315,0.36301873786184,0.537069381269275,4.03821350263437e-24
EPHA2,Ephrin type-A receptor 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,49644,0.416477953057504,0.0266126539125019,0.364317151389,0.468638754726007,4.52759991177652e-55
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X136.Number of operations, self-reported",49644,0.192299638732546,0.0254994341338291,0.142320747830241,0.242278529634851,4.73107909409814e-14
EPHA2,Ephrin type-A receptor 2,Health and medical history,X137.Number of treatments or medications taken,49644,0.475153799739298,0.0259375308279095,0.424316239316595,0.525991360162001,1.02727639722003e-74
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1438.Bread intake,48219,0.0131301923756348,0.00162652019132767,0.00994221280063256,0.016318171950637,7.04143447475739e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1458.Cereal intake,47121,0.182453143231701,0.0257666417791898,0.131950525344489,0.232955761118913,1.4513356493694e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1488.Tea intake,47922,0.00666234556371315,0.00155513070989629,0.00361428937231642,0.00971040175510987,1.83832284096796e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1498.Coffee intake,45789,-0.188103691855425,0.0257960558901442,-0.238663961400108,-0.137543422310743,3.10416901945479e-13
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1528.Water intake,45895,-0.0256477716444123,0.0259861255033507,-0.0765805776309796,0.0252850343421549,0.323657921837547
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1568.Average weekly red wine intake,33740,-0.50824300314467,0.0314435191533846,-0.569872300685304,-0.446613705604036,1.5106658960524e-58
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,33728,-0.241183409559249,0.0322224682849924,-0.304339447397835,-0.178027371720664,7.33209995484042e-14
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,33821,-0.0650465934192537,0.0349912560847054,-0.133629455345276,0.00353626850676886,0.0630445380447538
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1598.Average weekly spirits intake,33683,-0.00838912176009232,0.0340880528782298,-0.0752017054014227,0.0584234618812381,0.805605143692596
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1608.Average weekly fortified wine intake,33799,0.119140971812484,0.0552895722454408,0.0107734102114199,0.227508533413548,0.031180282798625
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1737.Childhood sunburn occasions,37267,-0.147809229901978,0.0306451062419557,-0.207873638136211,-0.0877448216677446,1.41789879941156e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1807.Father's age at death,36599,-0.00512500329240765,0.00182374065726901,-0.00869953498065492,-0.00155047160416039,0.00495431461410259
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1845.Mother's age,18831,-0.00931250128541565,0.00392576792276916,-0.0170070064140432,-0.0016179961567881,0.0176950186887945
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1873.Number of full brothers,48757,0.00755723888015654,0.0247827102315103,-0.0410168731736037,0.0561313509339168,0.760413176017913
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1883.Number of full sisters,48764,0.00612984212193427,0.0248474035616292,-0.042571068858859,0.0548307531027275,0.805141829620774
EPHA2,Ephrin type-A receptor 2,Physical measures,X20015.Sitting height,49275,0.000232406545608161,0.00205170672033573,-0.00378893862624987,0.00425375171746619,0.909813204362425
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20016.Fluid intelligence score,15970,-0.18281838182273,0.0414853905424393,-0.264129747285912,-0.101507016359549,1.05587153736453e-05
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20018.Prospective memory result,16634,0.237440282462708,0.0525210749019639,0.134498975654859,0.340381589270557,6.20150557953316e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),15767,0.0118934477700336,0.00279904151319559,0.00640732640417022,0.0173795691358969,2.15850792666101e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),15747,0.0100870920164632,0.00279812199035393,0.00460277291536951,0.0155714111175569,0.000313176883867383
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20023.Mean time to correctly identify matches,49050,0.0126656253992617,0.00164836963310838,0.00943482091836925,0.0158964298801541,1.5738578179128e-14
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,43191,-0.00664129904217411,0.00348801046981216,-0.0134777995630059,0.000195201478657725,0.0569120790556824
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,42347,-0.00856619606394832,0.00765733118643377,-0.0235745651893585,0.00644217306146186,0.263277855552561
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,42280,-0.00553439575489962,0.0102711925063117,-0.0256659330672705,0.0145971415574712,0.590009075435217
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,42316,0.00173956070647976,0.00872136679928818,-0.0153543182201251,0.0188334396330846,0.841904168098776
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,42341,-0.000666545368827822,0.00620877919924297,-0.012835752599344,0.0115026618616884,0.914507621792283
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#2.Illnesses of father_Stroke,42675,-0.00163489432260694,0.00448464678994253,-0.0104248020308943,0.00715501338568042,0.71544643145796
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,42556,-0.00106466446437129,0.00566180584338239,-0.0121618039174008,0.0100324749886582,0.850843631326509
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,42364,0.00131760072132524,0.00708660446603069,-0.0125721440320949,0.0152073454747454,0.852501835141422
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,42628,0.0114174893381812,0.00518444266089906,0.00125598172281905,0.0215789969535434,0.0276523023135435
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,42778,-0.000952963771095268,0.00390845928656663,-0.00861354397276587,0.00670761643057533,0.807370759918005
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,42504,0.00398129549771984,0.00540562306124687,-0.00661372570232403,0.0145763166977637,0.461424443913839
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,45276,0.00553011201251223,0.00400954279302412,-0.00232859186181505,0.0133888158868395,0.167828336173585
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,44998,-0.0140920549195134,0.00574534202280487,-0.0253529252842109,-0.00283118455481581,0.0141795044661001
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,44852,0.00814770822480117,0.0124845479916937,-0.0163220058389186,0.0326174222885209,0.514002438512824
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,44922,0.0123348662866571,0.00644555110633897,-0.000298413881767306,0.0249681464550815,0.0556645489782641
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,45156,0.00575036963151454,0.00457093051112097,-0.00320865417028256,0.0147093934333116,0.208387262020352
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,44946,0.00216800369498641,0.00803660866551321,-0.0135837492894195,0.0179197566793923,0.787341527749789
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,44911,-0.0051514148560014,0.0072606346205718,-0.0193822587123221,0.00907942900031932,0.478018397954678
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,44946,0.000210400796371174,0.00588411948381096,-0.0113224733918983,0.0117432749846407,0.97147596243753
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,44995,0.0253581494782438,0.00676502800302057,0.0120986945923235,0.0386176043641641,0.000178176366178525
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,45347,-0.00278404000282671,0.00346932047866415,-0.00958390814100845,0.00401582813535503,0.422282942335104
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45062,0.0121195937824336,0.00535882364416567,0.00161629943986892,0.0226228881249983,0.0237259714058217
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,38840,-0.00174066251311587,0.00557015761477272,-0.0126581714380704,0.00917684641183867,0.754663843070045
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,38560,0.0230065990781046,0.0217866775082538,-0.0196952888380729,0.0657084869942821,0.290977609034401
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,38548,0.0123544635332638,0.0224343453266283,-0.0316168533069276,0.0563257803734552,0.581846523449467
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,38662,0.00513124518656755,0.00655960266646354,-0.007725576039701,0.0179880664128361,0.434072815848872
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,38578,0.00630451816633833,0.0129728013714504,-0.0191221725217045,0.0317312088543812,0.626984317532328
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,38625,0.0249035699071899,0.00942033086226738,0.00643972141714583,0.043367418397234,0.00820630992506589
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,38580,0.0107266352047124,0.0111449691813335,-0.0111175043907012,0.0325707748001259,0.335822451288022
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,38581,0.0172778990129117,0.0107919615433288,-0.00387434561201268,0.0384301436378361,0.1093857542976
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,38603,0.00571667112854756,0.00820981612238699,-0.0103745684713309,0.0218079107284261,0.486231732174345
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,38627,0.0280606114103578,0.0100570781080924,0.00834873831849674,0.0477724845022189,0.00527118030037326
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,38977,0.00497354550585187,0.00417206153184402,-0.0032036950965624,0.0131507861082661,0.233226388688992
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,38761,0.0224963457138521,0.00590243480801367,0.0109275734901453,0.0340651179375589,0.000138413978409512
EPHA2,Ephrin type-A receptor 2,Mental health,X20127.Neuroticism score,39472,0.133295128414435,0.0261636867350233,0.082014302413789,0.18457595441508,3.50972742242435e-07
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,15970,-0.0580615164126683,0.0421768847611356,-0.140728210544494,0.0246051777191574,0.16864928897338
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X20161.Pack years of smoking,15092,0.0199303314328025,0.00312513637876497,0.0138050641304231,0.0260555987351818,1.85332359699027e-10
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15092,0.0190742530080173,0.00308236932250975,0.0130328091358982,0.0251156968801365,6.24368604000679e-10
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20191.Fluid intelligence score,12270,-0.0345275939042786,0.0490743365587385,-0.130713293559406,0.0616581057508489,0.481709371298707
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12271,-0.0426684391967481,0.050244636101096,-0.141147925954896,0.0558110475614,0.395778928131589
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20240.Maximum digits remembered correctly,11026,-0.108289700140043,0.052426230185821,-0.211045111304252,-0.00553428897583363,0.0388930859179383
EPHA2,Ephrin type-A receptor 2,Physical measures,X20255.Spirometry QC measure,36900,0.0547555440169166,0.0332435091866482,-0.0104017339889138,0.119912822022747,0.099545021547402
EPHA2,Ephrin type-A receptor 2,Eye measures,X20261.avMSE,10901,0.00376321377075477,0.00329135007904617,-0.00268783238417573,0.0102142599256853,0.252912308166917
EPHA2,Ephrin type-A receptor 2,Eye measures,X20262.Myopia diagnosis,10901,-0.00700411539796915,0.0635727332571836,-0.131606672582049,0.117598441786111,0.912272750429299
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X20280.Glucose-lactate,28279,0.00489366223279713,0.00211773214241477,0.000742907233664184,0.00904441723193009,0.0208508880356281
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,28339,0.0103288037747646,0.00212383760622152,0.00616608206657039,0.0144915254829587,1.1607877714992e-06
EPHA2,Ephrin type-A receptor 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,15470,-0.0142179162361098,0.0111297459524477,-0.0360322183029073,0.00759638583068766,0.201455563660796
EPHA2,Ephrin type-A receptor 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,15467,-0.0183695954759756,0.0219017712173613,-0.0612970670620037,0.0245578761100525,0.401635788925206
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),15466,-0.00414297025847754,0.0268907619147484,-0.0568488636113845,0.0485629230944294,0.877559176565493
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),15466,-0.024773029321477,0.010582561452228,-0.0455148497678438,-0.00403120887511017,0.0192484495109894
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),15466,-0.0548959086219828,0.0184252941617645,-0.0910094851790413,-0.0187823320649243,0.00289283619310012
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,15474,-0.0173798650847032,0.0238744105661983,-0.0641737097944518,0.0294139796250455,0.466642708584354
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,15474,-0.0329273520255491,0.0152706656228493,-0.0628578566463338,-0.00299684740476442,0.0310796292948998
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,15474,-0.0148100032946532,0.0170757350374621,-0.0482784439680788,0.0186584373787725,0.385784115284345
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,15474,-0.00208199436552569,0.026956467984458,-0.0549166716150633,0.0507526828840119,0.938437257125618
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,15474,0.0160359193031246,0.0314376487494564,-0.04558187224581,0.0776537108520591,0.609998164968445
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,15474,0.00319929322207513,0.0179675872309747,-0.0320171777506353,0.0384157641947856,0.858678859654197
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,15474,0.0191488149900954,0.0306994443929156,-0.0410220960200193,0.07931972600021,0.532800201547842
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,15474,-0.0123084548443481,0.0230281524587258,-0.0574436336634507,0.0328267239747545,0.593006118322152
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),15478,0.000436888426053108,0.030682470752293,-0.0597007542484411,0.0605745311005473,0.988639470470684
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),15478,-0.0176568219874711,0.0140613701288192,-0.0452171074399567,0.00990346346501463,0.209244775742982
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),15478,-0.0423470114167939,0.021225565787634,-0.0839491203605565,-0.000744902473031293,0.0460500818330462
EPHA2,Ephrin type-A receptor 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,15478,0.014895308577413,0.0354927784226791,-0.054670537131038,0.084461154285864,0.674731256922138
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20600.Liking for adding salt to foods,17901,-0.0334561782602604,0.0425278599036175,-0.116810783671351,0.0498984271508299,0.431474666091578
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20601.Liking for aniseed,17901,-0.0519413475704671,0.0423416237178998,-0.134930930057551,0.0310482349166165,0.219943728434679
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20602.Liking for apple juice,17901,0.164299982936312,0.0427040130463157,0.0806001173655335,0.247999848507091,0.000119786162188559
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20603.Liking for apples,17901,0.00616654509924315,0.0435675019714118,-0.0792257587647239,0.0915588489632102,0.887444941669349
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20604.Liking for asparagus,17901,-0.366518777812562,0.0430311064526021,-0.450859746459662,-0.282177809165462,1.75757971098627e-17
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20605.Liking for aubergine,17901,-0.398223501422634,0.0422110720333127,-0.480957202607927,-0.315489800237341,4.41485593555779e-21
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20606.Liking for avocados,17901,-0.356854583119381,0.0429733681319194,-0.441082384657943,-0.272626781580819,1.07693551236551e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20607.Liking for bacon,17901,-0.127784199992716,0.0426103957206538,-0.211300575605198,-0.0442678243802347,0.00271331464070451
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20608.Liking for baked or steamed fish,17901,-0.305732137616719,0.0430498825096697,-0.390109907335671,-0.221354367897766,1.27760940258856e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20609.Liking for bananas,17901,0.13513892606159,0.0440876306760136,0.0487271699366036,0.221550682186577,0.00217823597827271
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,17901,-0.304373088724875,0.0423914953466414,-0.387460419604292,-0.221285757845458,7.24222723058577e-13
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20611.Liking for beef steak,17901,-0.238350338580658,0.0428744938255273,-0.322384346478691,-0.154316330682624,2.74797994885449e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20612.Liking for beetroot,17901,-0.101941189524553,0.0431435497943115,-0.186502547121404,-0.0173798319277029,0.0181462731987695
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20613.Liking for bell pepper,17901,-0.246618665493145,0.0426723171648579,-0.330256407136266,-0.162980923850023,7.62332686631454e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20614.Liking for bicycling,17901,-0.0724670011663361,0.0423651754931863,-0.155502745132981,0.010568742800309,0.0871848345810705
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20615.Liking for biscuits,17901,0.339106836205567,0.0427945437218627,0.255229530510716,0.422984141900417,2.43286399214236e-15
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20616.Liking for bitter foods,17901,-0.31391135464998,0.0422304316316274,-0.396683000647969,-0.23113970865199,1.10703067672645e-13
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20617.Liking for bitter or ale,17901,-0.471701506851909,0.0433285525563477,-0.556625469862351,-0.386777543841468,1.62873368250664e-27
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20618.Liking for black olives,17901,-0.407145494898052,0.0427262154895063,-0.490888877257484,-0.323402112538619,1.78296831920117e-21
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20619.Liking for black pepper,17901,-0.249967931686871,0.0428915737669573,-0.334035416270107,-0.165900447103635,5.70932952667557e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20620.Liking for blue cheese,17901,-0.28756350370594,0.042356278980674,-0.370581810508061,-0.204545196903819,1.16332721151513e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20621.Liking for bolognese sauce,17901,-0.217786116869831,0.0427669944736736,-0.301609426038231,-0.133962807701431,3.57174582875485e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20622.Liking for broad beans,17901,-0.20046004309096,0.0427860322466901,-0.284320666294473,-0.116599419887447,2.81780506753414e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20623.Liking for broccoli,17901,-0.188130305076834,0.0438698304869802,-0.274115172831315,-0.102145437322353,1.8092851731895e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20624.Liking for brown rice,17901,-0.128359008915135,0.0422938339211983,-0.211254923400684,-0.0454630944295865,0.00240933865989601
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20625.Liking for brussel sprouts,17901,-0.1226060886083,0.0427059107409422,-0.206309673660547,-0.0389025035560537,0.00409734273630739
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20626.Liking for burgers (meat),17901,-0.0855215752465504,0.0422553386263252,-0.168342038954148,-0.00270111153895294,0.0429928609111232
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20627.Liking for burn of spicy foods,17901,-0.326867784360885,0.0425494315457938,-0.410264670190641,-0.243470898531129,1.64599660500331e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20628.Liking for butter on bread,17901,0.108619850061188,0.0430830235828409,0.0241771238388203,0.193062576283557,0.0117049828268621
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20629.Liking for butternut squash,17901,-0.229355353663911,0.0422139730930847,-0.312094740926357,-0.146615966401465,5.60877371624638e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20630.Liking for cabbage,17901,-0.0849183260893404,0.0429549853674605,-0.169110097409563,-0.000726554769117732,0.0480666549064683
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20631.Liking for cake,17901,0.370006249300203,0.0428493367348455,0.286021549299906,0.4539909493005,6.35638596139059e-18
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20632.Liking for cake icing,17901,0.287445769304357,0.0422724101626141,0.204591845385633,0.37029969322308,1.08043938138864e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20633.Liking for capers,17901,-0.468768598327966,0.0420540348133106,-0.551194506562055,-0.386342690093877,9.2323593652828e-29
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20634.Liking for cauliflower,17901,-0.112275634261115,0.0433065591050474,-0.197156490107008,-0.0273947784152226,0.00953371042497726
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20635.Liking for cereal or granola bar,17901,0.0942319568454082,0.0423640047252362,0.0111985075839453,0.177265406106871,0.0261380052749325
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20636.Liking for cheesecake,17901,0.171621176313611,0.0424456033926123,0.0884277936640905,0.254814558963131,5.29204134029116e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20637.Liking for cherries,17901,-0.153532468139018,0.044997720466703,-0.241728000253756,-0.0653369360242798,0.000646296099806778
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20638.Liking for chicken,17901,-0.153337875875897,0.0444391370667355,-0.240438584526698,-0.0662371672250952,0.000560811395406949
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20639.Liking for chilli pepper,17901,-0.392321845204749,0.0424741462064088,-0.47557117176931,-0.309072518640188,2.81975693787009e-20
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20640.Liking for chips or french fries,17901,0.114970513977966,0.0428855350201515,0.0309148653384688,0.199026162617463,0.00734985514830316
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20641.Liking for cigarette smoking,17901,-0.0650918531923337,0.0687597029036923,-0.199860870883571,0.0696771644989032,0.343826389512047
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20642.Liking for cod,17901,-0.240869634545098,0.0439012160652923,-0.326916018033071,-0.154823251057125,4.15242100234257e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20643.Liking for coffee with sugar,17901,0.172531381891625,0.0461065222447801,0.0821625982918559,0.262900165491394,0.000183120307805744
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20644.Liking for coffee without sugar,17901,-0.251718790036807,0.0429984793047734,-0.335995809474163,-0.167441770599451,4.87898111357125e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20645.Liking for coriander,17901,-0.331122451146582,0.0426116855208755,-0.414641354767498,-0.247603547525666,8.22672978046049e-15
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20646.Liking for corn flakes,17901,0.31837483175289,0.0424398582861237,0.235192709512088,0.401556953993693,6.59002489195188e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20647.Liking for cream,17901,0.119761957413325,0.0422936614603792,0.0368663809509815,0.202657533875668,0.00463564263333636
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20648.Liking for croissant,17901,0.11172160503006,0.0423735349047146,0.0286694766168189,0.1947737334433,0.00838165559933225
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20649.Liking for cucumber,17901,-0.0672367810415155,0.0429214934232013,-0.15136290815099,0.016889346067959,0.117247881430704
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20650.Liking for curry,17901,-0.297879582634456,0.0432382840807261,-0.382626619432679,-0.213132545836232,5.79528246839766e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20651.Liking for dairy products,17901,0.133734500064262,0.0433860737476692,0.0486977955188306,0.218771204609694,0.00205630955832019
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20652.Liking for dark chocolate,17901,-0.132359686495979,0.0429443890859295,-0.216530689104401,-0.0481886838875575,0.00205845745953517
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,17901,0.104714550352238,0.0440500865496727,0.0183763807148798,0.191052719989597,0.0174564973929074
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20654.Liking for dried fruit,17901,-0.00600260959991767,0.0428476344746218,-0.0899839731701765,0.0779787539703411,0.888588901785549
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20655.Liking for eggs,17901,-0.119040382528498,0.0437928582573986,-0.204874384712999,-0.0332063803439965,0.00656894773207843
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20656.Liking for exercising alone,17901,-0.15559262685465,0.042644878826174,-0.239176589353951,-0.0720086643553493,0.000264458941000197
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20657.Liking for exercising with others,17901,-0.0907446163302838,0.0422720416661878,-0.173597817996012,-0.00789141466455576,0.0318320467929566
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,17901,-0.350651317017075,0.0431841797449026,-0.435292309317084,-0.266010324717066,4.96634004408515e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20659.Liking for fatty foods,17901,0.0415961989346904,0.0420244458385024,-0.0407717149087742,0.123964112778155,0.322280598916188
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20660.Liking for fresh tomatoes,17901,-0.17432771183506,0.0453316540030842,-0.263177753681105,-0.085477669989015,0.000120671460004982
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20661.Liking for fried chicken,17901,-0.0720905765962863,0.0421013883534539,-0.154609297769056,0.0104281445764834,0.0868571221925774
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20662.Liking for fried or battered fish,17901,-0.0632594641194537,0.0425076911241375,-0.146574538722763,0.0200556104838559,0.136718783147391
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20663.Liking for fruit,17901,-0.0203967675619641,0.0472074584365792,-0.112923386097659,0.0721298509737311,0.665698196660434
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20664.Liking for garlic,17901,-0.359660575319207,0.0430651403925007,-0.444068250488508,-0.275252900149906,7.2243939174164e-17
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20665.Liking for gherkins,17901,-0.246818716326104,0.0422877250863778,-0.329702657495405,-0.163934775156804,5.4181520725909e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20666.Liking for globe artichoke,17901,-0.336141775974495,0.0421697032346829,-0.418794394314473,-0.253489157634516,1.66582153791713e-15
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20667.Liking for goat's cheese,17901,-0.338966429786648,0.0420473999467533,-0.421379333682284,-0.256553525891011,8.00611857669539e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20668.Liking for going to a cafe,17901,0.133999875250599,0.0425142163443776,0.0506720112156191,0.217327739285579,0.00162488603593544
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20669.Liking for going to the gym,17901,-0.160664415752712,0.0422345828989571,-0.243444198234668,-0.0778846332707562,0.000142796526143581
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20670.Liking for going to the pub,17901,-0.45724381202572,0.0422716020940026,-0.540096152129965,-0.374391471921475,3.47889405648696e-27
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20671.Liking for grapefruit,17901,-0.0401759467654134,0.0425008792844801,-0.123477670162994,0.0431257766321676,0.344520127915879
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20672.Liking for green olives,17901,-0.43069594807151,0.0427079061734682,-0.514403444171508,-0.346988451971512,7.47875697621273e-24
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20673.Liking for haddock,17901,-0.315601724691458,0.0436251159872375,-0.401106952026443,-0.230096497356472,4.8650248400735e-13
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20674.Liking for ham,17901,-0.135603981282689,0.0426573136154404,-0.219212315968952,-0.0519956465964254,0.00148079237043493
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20675.Liking for hard cheese,17901,0.020969114749948,0.0433815706004544,-0.0640587636269427,0.105996993126839,0.628842811056763
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20676.Liking for herring,17901,-0.269508982064139,0.0420462160265993,-0.351919565476274,-0.187098398652005,1.49328574339654e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20677.Liking for honey,17901,0.0500077187951731,0.0424999446342341,-0.0332921726879256,0.133307610278272,0.239349405002053
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,17901,-0.359894227763848,0.0422009478545749,-0.442608085558814,-0.277180369968881,1.60472800538912e-17
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20679.Liking for ice cream,17901,0.221831796391372,0.0428218879868311,0.137900895937184,0.305762696845561,2.23890737251496e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20680.Liking for jam,17901,0.259117466825308,0.042636400332809,0.175550122173002,0.342684811477614,1.24641158778959e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20681.Liking for kiwi fruit,17901,-0.0377404179864959,0.0429348770142782,-0.121892776934481,0.0464119409614894,0.379404741278292
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20682.Liking for lager,17901,-0.324877682983608,0.042714702418974,-0.408598499724797,-0.241156866242419,2.97254329050878e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20683.Liking for lamb,17901,-0.250188840920609,0.0430438529130151,-0.334554792630119,-0.1658228892111,6.26248735316113e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20684.Liking for lemons,17901,-0.221488054162676,0.0425528249753415,-0.304891591114345,-0.138084517211006,1.96127416547878e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20685.Liking for lentils or beans,17901,-0.122911968652333,0.0429365871405927,-0.207067679447895,-0.0387562578567714,0.0042061645224547
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20686.Liking for liver,17901,-0.260807128681117,0.0427926689645371,-0.344680759851609,-0.176933497510624,1.1191273067877e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20687.Liking for mackerel,17901,-0.325667947110681,0.0425727022889559,-0.409110443597035,-0.242225450624328,2.1166816640146e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20688.Liking for marzipan,17901,0.147495366690307,0.0422968404015019,0.0645935595033633,0.230397173877251,0.000489372446448869
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20689.Liking for mayonnaise,17901,-0.0825935348223353,0.0426268478190215,-0.166142156547617,0.000955086902946933,0.0526884741775135
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20690.Liking for melon,17901,-0.0327516395085395,0.0440240847762423,-0.119038845669974,0.0535355666528954,0.456917578810081
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20691.Liking for milk chocolate,17901,0.195815434399481,0.0426349471206836,0.112250938042941,0.279379930756021,4.40239162038216e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20692.Liking for mushrooms,17901,-0.228250490561565,0.0438595124237572,-0.314215134912129,-0.142285846211001,1.97064644574523e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20694.Liking for orange juice,17901,0.087049625085067,0.0427513693846965,0.00325694109106181,0.170842309079072,0.041746659262455
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20695.Liking for oranges,17901,-0.0815229435048425,0.0434771628866827,-0.166738182762741,0.00369229575305559,0.0607986867516579
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20696.Liking for pasta,17901,-0.0688064940464101,0.0429472240165205,-0.15298305311879,0.0153700650259701,0.109147322126965
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20697.Liking for pears,17901,0.10456981487371,0.0433566662129065,0.0195907490964134,0.189548880651007,0.015881779533498
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20698.Liking for pizza,17901,0.0306134816277203,0.0422890011567275,-0.0522729606394656,0.113499923894906,0.46912972482595
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20699.Liking for plain yogurt,17901,-0.231449026785091,0.0425093840520196,-0.314767419527049,-0.148130634043132,5.25892631241695e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20700.Liking for plums,17901,0.00972328227753457,0.0435929375105284,-0.0757188752431011,0.0951654397981702,0.823501326300843
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20701.Liking for pollock,17901,-0.27713518358016,0.0418231430285159,-0.359108543916051,-0.195161823244269,3.53882759438992e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20702.Liking for pork chop,17901,-0.196621225977093,0.0424970355076943,-0.279915415572174,-0.113327036382012,3.74136406562177e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20703.Liking for porridge,17901,0.0799252800078367,0.0431588975920067,-0.00466615927249647,0.16451671928817,0.0640589302038687
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20704.Liking for potato crisps,17901,0.0882009996251715,0.0427241348626853,0.00446169529430838,0.171940303956035,0.038991323789837
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20705.Liking for potatoes,17901,0.171391262226494,0.0432963924376475,0.0865303330487048,0.256252191404283,7.56954208310758e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20706.Liking for prawns,17901,-0.41815445569258,0.0432426964376725,-0.502910140710418,-0.333398770674742,4.58214223007606e-22
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20707.Liking for raw carrots,17901,-0.0584774589567616,0.042920017155159,-0.142600692580873,0.0256457746673501,0.173065128629105
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20708.Liking for red meat,17901,-0.222477479882187,0.0426350651447355,-0.306042207565868,-0.138912752198505,1.82707240347707e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20709.Liking for red wine,17901,-0.623065528965715,0.0425927862510604,-0.706547390017794,-0.539583667913637,3.51296115326481e-48
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,17901,0.160831923158319,0.0437582269176819,0.075065798399662,0.246598047916975,0.000238108833735283
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20711.Liking for roast chicken,17901,-0.19110119013636,0.0442978223750688,-0.277924921991495,-0.104277458281225,1.61180744472527e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20712.Liking for salad dressing,17901,-0.122471618852024,0.042417330720324,-0.205609587063859,-0.0393336506401891,0.00389027518987446
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20713.Liking for salad leaves,17901,-0.184125023185058,0.0433114081436579,-0.269015383146628,-0.0992346632234888,2.1371636326788e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20714.Liking for salami,17901,-0.3355667071481,0.042401290312523,-0.418673236160645,-0.252460178135555,2.6358204597434e-15
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20715.Liking for salmon,17901,-0.353427267084603,0.0446612771365699,-0.44096337027228,-0.265891163896926,2.64772466701935e-15
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20716.Liking for salty foods,17901,-0.039828817443798,0.0420891906545204,-0.122323631126658,0.042665996239062,0.344010607945223
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20717.Liking for salty pretzels,17901,-0.112861697802386,0.0424611200507858,-0.196085493101927,-0.0296379025028463,0.0078675599591512
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20718.Liking for sardines,17901,-0.344243284065481,0.0426029668922095,-0.427745099174212,-0.260741468956751,6.87097787108786e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20719.Liking for sausages (meat),17901,-0.118751283135284,0.0424314443732376,-0.201916914106829,-0.0355856521637379,0.00513697170444808
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20720.Liking for savoury biscuits,17901,0.0408753105417952,0.0426859638945792,-0.04278917869158,0.12453979977517,0.338286529710238
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),17901,-0.494199279865216,0.0424766847397757,-0.577453581955176,-0.410944977775255,3.56027306614124e-31
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20722.Liking for skimmed milk,17901,-0.171368842442954,0.042124022213973,-0.253931925982341,-0.0888057589035672,4.75814859216979e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20723.Liking for smoked fish,17901,-0.324743831238672,0.0427545708377132,-0.408542790080589,-0.240944872396754,3.21609211911259e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20724.Liking for soft cheese,17901,-0.189353469204498,0.042390551185043,-0.272438949527182,-0.106267988881814,7.98554348091052e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20725.Liking for soy sauce,17901,-0.286386414447883,0.0427565645261661,-0.370189280919169,-0.202583547976598,2.17479984132704e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20726.Liking for soya milk,17901,-0.0484999058718367,0.0424384802559277,-0.131679327173455,0.0346795154297816,0.253125096000037
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20727.Liking for spicy foods,17901,-0.301739972115765,0.0426661206661866,-0.385365568621491,-0.218114375610039,1.58223646905373e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20728.Liking for spinach,17901,-0.294107795382886,0.0431626895154091,-0.378706666833088,-0.209508923932684,9.79910909821344e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20729.Liking for spirits,17901,-0.441063566905567,0.0424280804278384,-0.52422260454413,-0.357904529267003,3.06562555615751e-25
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20730.Liking for strawberries,17901,0.000766385988968242,0.0465680251145328,-0.0905069432355161,0.0920397152134526,0.986869716013873
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,17901,0.0977726431256948,0.043375982142801,0.0127557181258049,0.182789568125585,0.0242036139722293
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20732.Liking for sweet foods,17901,0.41397394526011,0.0426447814648442,0.330390173589016,0.497557716931205,3.17873277160131e-22
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20733.Liking for taking the stairs,17901,-0.258518313915393,0.0432678528422704,-0.343323305486243,-0.173713322344543,2.34689149428761e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20734.Liking for tea with sugar,17901,0.231377275511713,0.0507422420142494,0.131922481163784,0.330832069859642,5.15284826717996e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20735.Liking for tea without sugar,17901,-0.165868244685198,0.0445076917050777,-0.25310332042715,-0.0786331689432457,0.000194575917768642
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20736.Liking for tomato ketchup,17901,0.0500241859097826,0.0420973210279399,-0.0324865633049795,0.132534935124545,0.234731590263356
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20737.Liking for tinned tuna,17901,-0.184944690293736,0.042919613703987,-0.26906713315355,-0.100822247433922,1.64799597754958e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20738.Liking for turnip (white),17901,-0.0940445841422955,0.0423237690596457,-0.176999171499201,-0.01108999678539,0.0262939064160703
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20739.Liking for vegetables,17901,-0.119529565306627,0.0469190694900817,-0.211490941507187,-0.0275681891060671,0.010855938160179
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20740.Liking for vinegar,17901,-0.124860253773914,0.0426216303864579,-0.208398649331372,-0.0413218582164569,0.00339931944849082
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20741.Liking for watching television,17901,0.202250177353621,0.0429858205595077,0.117997969056986,0.286502385650256,2.55710638044099e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20742.Liking for whisky,17901,-0.305988663271164,0.0439310996228611,-0.392093618531972,-0.219883708010357,3.39358193613747e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20743.Liking for white bread,17901,0.174890316532368,0.0421559587755707,0.0922646373322499,0.257515995732487,3.35987540216398e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20744.Liking for white rice,17901,0.0295384997353338,0.0426389527397189,-0.0540338476345152,0.113110847105183,0.488470077175028
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20745.Liking for white wine,17901,-0.462642724977585,0.0425938475635362,-0.546126666202116,-0.379158783753054,2.13605764001926e-27
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,17901,-0.102693028456032,0.0429669734653828,-0.186908296448182,-0.0184777604638818,0.0168565695861488
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20747.Liking for whole milk,17901,0.133112897066351,0.0423508666656634,0.0501051984016509,0.216120595731051,0.00167443441212698
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20748.Liking for wholemeal bread,17901,-0.0967691688958184,0.044319609752433,-0.183635604010587,-0.00990273378104972,0.0290164452829106
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20749.Liking for working up a sweat,17901,-0.175229897015443,0.042474609157171,-0.258480130963498,-0.091979663067388,3.71569928827637e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X21001.Body mass index (BMI),49412,-0.121803795286502,0.00674257988472149,-0.135019251860556,-0.108588338712448,1.03412244053843e-72
EPHA2,Ephrin type-A receptor 2,Physical measures,X21002.Weight,49451,0.00625106056376489,0.00381396051545499,-0.00122430204652689,0.0137264231740567,0.101220754336011
EPHA2,Ephrin type-A receptor 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,16514,3.30123623860117e-05,0.00277338958113955,-0.0054028312166475,0.00546885594141953,0.990502945085858
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17090,0.0666441237354046,0.0453105074028113,-0.0221644707741057,0.155452718244915,0.141355109917794
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17108,-0.0600728416157574,0.0468561322938765,-0.151910860911755,0.0317651776802405,0.199835481242366
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17110,0.0217835751636586,0.046109813211072,-0.0685916587300426,0.11215880905736,0.6366272250574
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21040.Satisfaction with bowel habits,17036,0.0555155672117999,0.0427210543692424,-0.0282176993519152,0.139248833775515,0.193793557472286
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17018,0.117128707284881,0.045604241293261,0.0277443943500892,0.206513020219672,0.0102261733338241
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21042.Greatest number of times bowels opened per day,17029,0.0061569433442494,0.0460934523358607,-0.0841862232340376,0.0965001099225364,0.89374005465323
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21043.Least number of times bowels opened per week,16904,-0.0588986224083918,0.0460039393737017,-0.149066343580847,0.0312690987640635,0.200458921435675
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21044.Average number of times bowels opened per day,16964,0.0809611338757469,0.0514910332331198,-0.0199612912611678,0.181883559012662,0.115891643013525
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17119,-0.109961980636647,0.0464438758519386,-0.200991977306447,-0.0189319839668475,0.0179134209224289
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17109,-0.055274579619727,0.0468347501450736,-0.147070689904071,0.0365215306646172,0.237935340180902
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,9636,-0.0103089921757142,0.0746784325123189,-0.156678719899859,0.136060735548431,0.890207657798944
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17115,-2.38756549386441e-05,0.0510403886815135,-0.100063037470705,0.100015286160828,0.999626771312975
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17111,0.0452305060519354,0.0703701103579048,-0.092694910249558,0.183155922353429,0.520393866616318
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17112,-0.17250712119167,0.0545037880377398,-0.27933454574564,-0.0656796966377001,0.00155329084770159
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17110,-0.4234064940874,0.128253114496437,-0.674782598500416,-0.172030389674384,0.000964230808626509
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17118,0.0844999270178546,0.0539054911039611,-0.0211548355459092,0.190154689581618,0.117003066608938
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17114,-0.255604980496289,0.0526874784874989,-0.358872438331787,-0.152337522660791,1.23708801370794e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,16724,0.222174153530574,0.0485799237129912,0.126957503053111,0.317390804008037,4.83378932032976e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17108,-0.0463342908190855,0.0478297725365428,-0.140080644990709,0.0474120633525383,0.332692006835438
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17115,-0.26480258053932,0.0685213344684938,-0.399104396097568,-0.130500764981072,0.000111715486428452
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17118,-0.196499166953701,0.0469129898401463,-0.288448627040388,-0.104549706867014,2.82102643934422e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17115,0.0607795166123959,0.046724512126549,-0.0308005271556401,0.152359560380432,0.193342463015671
EPHA2,Ephrin type-A receptor 2,Working and living environment,X21100.Water hardness (USGS classification),49151,0.0188379089454626,0.0250104686198153,-0.0301826095493754,0.0678584274403005,0.45133277206528
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2139.Age first had sexual intercourse,42870,0.00173569075628937,0.00173478119709331,-0.00166448039001352,0.00513586190259226,0.317062489197158
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2149.Lifetime number of sexual partners,39779,-0.155172037275289,0.0285136415680576,-0.211058774748682,-0.0992852998018961,5.29879755049476e-08
EPHA2,Ephrin type-A receptor 2,Physical activities,X22032.IPAQ activity group,39780,-0.141630551915489,0.0280893674160812,-0.196685712051008,-0.08657539177997,4.62370970554135e-07
EPHA2,Ephrin type-A receptor 2,Physical activities,X22033.Summed days activity,40823,-0.0140221109510743,0.00168675635506045,-0.0173281534069928,-0.0107160684951559,9.61098750335918e-17
EPHA2,Ephrin type-A receptor 2,Physical activities,X22034.Summed minutes activity,39780,-0.0100297742100956,0.00169834576607756,-0.0133585319116076,-0.00670101650858354,3.54184911336879e-09
EPHA2,Ephrin type-A receptor 2,Physical activities,X22037.MET minutes per week for walking,38071,-0.00800035968540953,0.00172285903521641,-0.0113771633944337,-0.00462355597638536,3.43444533867065e-06
EPHA2,Ephrin type-A receptor 2,Physical activities,X22038.MET minutes per week for moderate activity,39780,-0.00754173794851573,0.00170176071395972,-0.0108771889478768,-0.00420628694915468,9.37311917998715e-06
EPHA2,Ephrin type-A receptor 2,Physical activities,X22039.MET minutes per week for vigorous activity,39780,-0.210153348106655,0.0281799136918635,-0.265385978942707,-0.154920717270602,8.99320331206811e-14
EPHA2,Ephrin type-A receptor 2,Physical activities,X22040.Summed MET minutes per week for all activity,38071,-0.00848295120910504,0.00172873192547272,-0.0118712657830316,-0.0050946366351785,9.28442725321422e-07
EPHA2,Ephrin type-A receptor 2,Eye measures,X2217.Age started wearing glasses or contact lenses,42216,-0.00387471616456106,0.00170259057020076,-0.00721179368215454,-0.000537638646967573,0.0228643590178726
EPHA2,Ephrin type-A receptor 2,Working and living environment,X22501.Year ended full time education,12048,-0.0277783575961836,0.00736665145857295,-0.0422169944549866,-0.0133397207373806,0.000163487061269311
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X22506.Tobacco smoking,11967,-0.16111894441453,0.106873378808376,-0.370590766878946,0.048352878049887,0.131691420143132
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46407,-0.145494174064142,0.0687777739759776,-0.280298611057058,-0.010689737071226,0.0343991157287955
EPHA2,Ephrin type-A receptor 2,Physical measures,X23098.Weight,48611,0.00896969321211208,0.00382715202000084,0.00146847525291043,0.0164709111713137,0.0190975694450663
EPHA2,Ephrin type-A receptor 2,Physical measures,X23099.Body fat percentage,48582,-0.0433722258986344,0.00366002353643575,-0.0505458720300485,-0.0361985797672203,2.3774274419723e-32
EPHA2,Ephrin type-A receptor 2,Physical measures,X23100.Whole body fat mass,48529,-0.0276553418055111,0.00353366999113431,-0.0345813349881344,-0.0207293486228879,5.12811122813596e-15
EPHA2,Ephrin type-A receptor 2,Physical measures,X23101.Whole body fat-free mass,48605,0.0268919117587943,0.00319746343672503,0.0206248834228132,0.0331589400947753,4.19601586766631e-17
EPHA2,Ephrin type-A receptor 2,Physical measures,X23102.Whole body water mass,48611,0.0269633807203098,0.00320147326444821,0.0206884931219913,0.0332382683186283,3.79501549574971e-17
EPHA2,Ephrin type-A receptor 2,Physical measures,X23104.Body mass index (BMI),48611,-0.112885451545065,0.00674732751126698,-0.126110213467149,-0.0996606896229822,1.17943686748381e-62
EPHA2,Ephrin type-A receptor 2,Physical measures,X23105.Basal metabolic rate,48609,0.0263174869562341,0.00342185801813878,0.0196106452406821,0.0330243286717861,1.48736500682527e-14
EPHA2,Ephrin type-A receptor 2,Physical measures,X23106.Impedance of whole body,48605,-0.0171173733283948,0.00261873317040084,-0.0222500903423804,-0.0119846563144091,6.35928282300366e-11
EPHA2,Ephrin type-A receptor 2,Physical measures,X23107.Impedance of leg (right),48608,-0.0370830526205117,0.00212857840555057,-0.0412550662953908,-0.0329110389456326,9.11164692827563e-68
EPHA2,Ephrin type-A receptor 2,Physical measures,X23108.Impedance of leg (left),48607,-0.0363333170893139,0.00211594054740844,-0.0404805605622344,-0.0321860736163933,6.82794321447513e-66
EPHA2,Ephrin type-A receptor 2,Physical measures,X23109.Impedance of arm (right),48598,0.0133342930303947,0.00261064738660744,0.00821742415264412,0.0184511619081453,3.27407468621564e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X23110.Impedance of arm (left),48606,0.0111309632576199,0.00261294298669656,0.0060095950036947,0.0162523315115452,2.04871958717671e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X23111.Leg fat percentage (right),48607,-0.0984946840329154,0.0044121012637322,-0.10714240250983,-0.0898469655560003,7.76763863965753e-110
EPHA2,Ephrin type-A receptor 2,Physical measures,X23112.Leg fat mass (right),48606,-0.0679381073305896,0.00470756943067894,-0.0771649434147203,-0.0587112712464588,4.09432361553508e-47
EPHA2,Ephrin type-A receptor 2,Physical measures,X23113.Leg fat-free mass (right),48605,0.0525485905977115,0.0033393752403994,0.0460034151265287,0.0590937660688943,1.17548029242635e-55
EPHA2,Ephrin type-A receptor 2,Physical measures,X23114.Leg predicted mass (right),48604,0.0527866558107288,0.00335551217861498,0.0462098519406435,0.0593634596808142,1.26617372582921e-55
EPHA2,Ephrin type-A receptor 2,Physical measures,X23115.Leg fat percentage (left),48601,-0.103844952523982,0.00459840727808896,-0.112857830789036,-0.0948320742589274,2.42814803813261e-112
EPHA2,Ephrin type-A receptor 2,Physical measures,X23116.Leg fat mass (left),48601,-0.0700328093114257,0.00491205417144198,-0.079660435487452,-0.0604051831353994,4.99913555516928e-46
EPHA2,Ephrin type-A receptor 2,Physical measures,X23117.Leg fat-free mass (left),48598,0.0512784733553277,0.00348909898221793,0.0444398393501806,0.0581171073604748,8.60867913118409e-49
EPHA2,Ephrin type-A receptor 2,Physical measures,X23118.Leg predicted mass (left),48597,0.0511137285254593,0.0035069118780713,0.0442401812444395,0.057987275806479,5.10748911566348e-48
EPHA2,Ephrin type-A receptor 2,Physical measures,X23119.Arm fat percentage (right),48597,-0.0253213798966031,0.00407691776683046,-0.0333121387195908,-0.0173306210736154,5.31033187422379e-10
EPHA2,Ephrin type-A receptor 2,Physical measures,X23120.Arm fat mass (right),48592,-0.0217733575457433,0.00404005410589687,-0.0296918635933011,-0.0138548514981854,7.10324739255086e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X23121.Arm fat-free mass (right),48593,0.00824889753404636,0.00322182754216572,0.00193411555140156,0.0145636795166912,0.0104606898771276
EPHA2,Ephrin type-A receptor 2,Physical measures,X23122.Arm predicted mass (right),48592,0.00806593294108817,0.00322548165745006,0.00174398889248606,0.0143878769896903,0.0123983945476635
EPHA2,Ephrin type-A receptor 2,Physical measures,X23123.Arm fat percentage (left),48587,-0.0248865513036518,0.0041743623279134,-0.0330683014663621,-0.0167048011409416,2.51251426831407e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23124.Arm fat mass (left),48586,-0.0237496215998712,0.00403140808569091,-0.0316511814478254,-0.015848061751917,3.86042023361954e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23125.Arm fat-free mass (left),48582,0.00752342345021916,0.00328138263885278,0.0010919134780677,0.0139549334223706,0.0218660693461435
EPHA2,Ephrin type-A receptor 2,Physical measures,X23126.Arm predicted mass (left),48579,0.00816351795806734,0.00329348866373063,0.00170828017715531,0.0146187557389794,0.0131901740450485
EPHA2,Ephrin type-A receptor 2,Physical measures,X23127.Trunk fat percentage,48575,-0.0177969315328781,0.00263077888818957,-0.0229532581537297,-0.0126406049120266,1.34918131671954e-11
EPHA2,Ephrin type-A receptor 2,Physical measures,X23128.Trunk fat mass,48571,-0.0147005527053713,0.00289476736631575,-0.0203742967433502,-0.00902680866739248,3.82194203957514e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X23129.Trunk fat-free mass,48565,0.0133571410100851,0.00290020614259012,0.00767273697060843,0.0190415450495617,4.12353520868192e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,X23130.Trunk predicted mass,48561,0.0134858096563666,0.00290126509616944,0.00779933006787449,0.0191722892448587,3.35639605680876e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23400.Total Cholesterol,28347,-0.0383827401055448,0.00213335499390452,-0.0425641158935977,-0.034201364317492,5.6944898392411e-72
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,28347,-0.0279292289660632,0.00207399713791479,-0.0319942633563762,-0.0238641945757502,3.30360375682117e-41
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",28347,-0.0203679750975929,0.0020802230303847,-0.0244452122371469,-0.0162907379580389,1.33344623526719e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23403.VLDL Cholesterol,28347,-0.00464772861757384,0.00208795747327123,-0.00874012526518545,-0.000555331969962242,0.026024092861847
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,28347,-0.0346879295180865,0.00207375572946714,-0.0387524907478421,-0.030623368288331,1.66038412069279e-62
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23405.LDL Cholesterol,28347,-0.033629065060656,0.00206795602555246,-0.0376822588707388,-0.0295758712505732,3.40762656388036e-59
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23406.HDL Cholesterol,28347,-0.0521597643557218,0.00239177049523583,-0.056847634526384,-0.0474718941850596,1.41338481420303e-104
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23407.Total Triglycerides,28347,0.0115441090359867,0.00220886521056272,0.00721473322328381,0.0158734848486897,1.741952860843e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23408.Triglycerides in VLDL,28347,0.00949431321208034,0.00222518139494937,0.00513295767797958,0.0138556687461811,1.98976319167311e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23409.Triglycerides in LDL,28347,0.0113356072081569,0.00214381061926469,0.00713373839439807,0.0155374760219157,1.24851353156812e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23410.Triglycerides in HDL,28347,0.0189590968140893,0.00212878410892959,0.0147866799605873,0.0231315136675913,5.5964463709656e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,28347,-0.0350488691325007,0.00216559474115912,-0.0392934348251726,-0.0308043034398288,1.19131406970102e-58
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23412.Phospholipids in VLDL,28347,0.00343731902015987,0.00213541409392719,-0.000748092603937426,0.00762273064425717,0.107480340502536
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23413.Phospholipids in LDL,28347,-0.0324044671145966,0.00206452713456382,-0.0364509402983417,-0.0283579939308515,2.76267901703873e-55
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23414.Phospholipids in HDL,28347,-0.0399187174186998,0.0023144097247671,-0.0444549604792433,-0.0353824743581563,2.53295094167826e-66
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23415.Total Esterified Cholesterol,28347,-0.0411275506730422,0.00214225740701422,-0.0453263751907901,-0.0369287261552943,1.26475281017958e-81
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,28347,-0.00725195637103776,0.00207604483667689,-0.0113210042509245,-0.00318290849115104,0.000478068535750367
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,28347,-0.0318853311724664,0.0020645130242237,-0.0359317766999449,-0.027838885644988,1.35968679243878e-53
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,28347,-0.0538500408230952,0.00238276866608742,-0.0585202674086266,-0.0491798142375639,4.27292839760725e-112
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23419.Total Free Cholesterol,28347,-0.0310515405088062,0.00211209392222183,-0.035191244596361,-0.0269118364212514,9.49808804653443e-49
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,28347,-0.0010834852086906,0.00211580283951852,-0.00523045877414689,0.00306348835676569,0.608590779711637
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23421.Free Cholesterol in LDL,28347,-0.0372939476734101,0.00208675634821906,-0.0413839901159194,-0.0332039052309007,4.81183617597594e-71
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23422.Free Cholesterol in HDL,28347,-0.0423569002905703,0.00239682011923405,-0.0470546677242691,-0.0376591328568716,1.62457959051622e-69
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,28347,-0.0270934327450871,0.00209540594965448,-0.0312004284064099,-0.0229864370837644,3.91246592530004e-38
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23424.Total Lipids in VLDL,28347,0.00438284111409741,0.00216243847240493,0.000144461708183736,0.00862122052001108,0.0426917046463344
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23425.Total Lipids in LDL,28347,-0.0313600417547806,0.00206643265988838,-0.0354102497681618,-0.0273098337413993,8.16382274867126e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23426.Total Lipids in HDL,28347,-0.0433042704153423,0.00234476521873243,-0.0479000102440579,-0.0387085305866268,1.03139845476177e-75
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,28347,-0.053553685435616,0.0021907126276647,-0.0578474821858388,-0.0492598886853932,1.26100655335578e-130
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23428.Concentration of VLDL Particles,28347,0.00148108457724148,0.00210515739661892,-0.0026450239201316,0.00560719307461456,0.481718517096821
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23429.Concentration of LDL Particles,28347,-0.0205220832382853,0.00206613656024858,-0.0245717108963726,-0.0164724555801981,3.27793295782031e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23430.Concentration of HDL Particles,28347,-0.0533135178523385,0.00219899842564792,-0.0576235547666085,-0.0490034809380686,1.5461094328886e-128
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,28347,0.00570329039129161,0.0023121081918461,0.00117155833527326,0.01023502244731,0.0136421113269655
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,28347,-0.0174146911386905,0.0021658378679552,-0.0216597333598827,-0.0131696489174983,9.28389096987235e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,28347,-0.0102214201937595,0.00246944149586044,-0.0150615255256459,-0.005381314861873,3.49582823261758e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23434.Phosphoglycerides,28326,-0.0340095004352375,0.00218082596448382,-0.0382839193256258,-0.0297350815448492,1.33345909986374e-54
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,28326,0.0327237005341916,0.00233759635659687,0.0281420116752617,0.0373053893931214,2.22730461255917e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23436.Total Cholines,28326,-0.0365849788642269,0.0021986810519862,-0.0408943937261199,-0.032275564002334,7.09818479275407e-62
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23437.Phosphatidylcholines,28326,-0.0329963905011143,0.00220944300774986,-0.037326898796304,-0.0286658822059246,3.06550823742059e-50
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23438.Sphingomyelins,28325,-0.0414322609782688,0.00221161620618451,-0.0457670287423905,-0.0370974932141472,7.74893656164721e-78
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23439.Apolipoprotein B,28347,-0.0190187271069226,0.00206869261885945,-0.0230733646398871,-0.0149640895739581,4.05187085029405e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23440.Apolipoprotein A1,28347,-0.0449739576005878,0.00228063643071649,-0.0494440050047921,-0.0405039101963835,5.49520158825e-86
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,28347,0.00488552095187964,0.00211534919437768,0.00073943653089938,0.00903160537285989,0.0209198094793993
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23442.Total Fatty Acids,28326,-0.0133920000085264,0.00210660942479385,-0.0175209544811224,-0.0092630455359305,2.08681911715026e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23443.Degree of Unsaturation,28326,-0.0590261976966043,0.00224909058377112,-0.0634344152407957,-0.0546179801524129,5.16171008003601e-150
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,28326,-0.0467752943419053,0.00213016529222883,-0.0509504183146738,-0.0426001703691368,5.51196276998751e-106
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,28326,-0.0221089164715734,0.00210487824280872,-0.0262344778274785,-0.0179833551156683,9.26808940802846e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,28326,-0.0306972544539668,0.00211127139240967,-0.0348353463830897,-0.0265591625248438,1.00912923501138e-47
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,28326,0.00672040113242521,0.0021607365891501,0.00248535741769101,0.0109554448471594,0.00187123385504793
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23448.Saturated Fatty Acids,28326,-0.0140965459514392,0.00211719271100728,-0.0182462436650135,-0.00994684823786499,2.82400164342697e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23449.Linoleic Acid,28326,-0.00962268396116304,0.00210011164607897,-0.0137389027874778,-0.00550646513484826,4.62542538952683e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23450.Docosahexaenoic Acid,28326,-0.0584727925576474,0.00217904802113638,-0.0627437266790747,-0.0542018584362201,1.1814878569451e-156
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,28326,-0.049934336043557,0.00214576769334991,-0.0541400407225228,-0.0457286313645911,1.13325921057243e-118
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,28326,-0.00594804517776122,0.00225733085281375,-0.0103724136492762,-0.00152367670624627,0.00841854758427537
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,28326,-0.0288050366343993,0.00229347156981021,-0.0333002409112273,-0.0243098323575713,4.39608819280157e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,28326,0.0488603588045587,0.00231924384411593,0.0443146408700915,0.0534060767390259,8.93407511984961e-98
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,28326,-0.00787496910630623,0.00211849488972377,-0.0120272190901648,-0.00372271912244765,0.000201793247513593
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,28326,0.00757229921215761,0.00225329852978165,0.00315583409378558,0.0119887643305296,0.00077893114251109
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,28326,-0.0516953898906418,0.0021972128405035,-0.0560019270580287,-0.047388852723255,3.09903132812281e-121
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,28326,-0.0419371805224249,0.00232592615445833,-0.0464959957851632,-0.0373783652596865,2.8603337278054e-72
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,28324,0.0432078240713636,0.00212917750188542,0.0390346361676682,0.047381011975059,6.55510823461353e-91
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23460.Alanine,28339,0.00921628230402213,0.00210380066845468,0.00509283299385097,0.0133397316141933,1.18680983218381e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23461.Glutamine,28265,0.00661085544592816,0.00209489579804816,0.00250485968175376,0.0107168512101026,0.00160283370396842
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23462.Glycine,28316,0.0462501963487801,0.00219527735363536,0.0419474527356548,0.0505529399619054,8.81464851051102e-98
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23463.Histidine,28312,-0.0039593365958483,0.00207553207489369,-0.00802737946263994,0.000108706270943334,0.0564498310616471
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),28327,-0.0204407188009513,0.00220237151143631,-0.0247573669633665,-0.0161240706385361,1.79122637197227e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23465.Isoleucine,28342,-0.00792926150143813,0.00214823251573528,-0.0121397972322793,-0.00371872577059699,0.000223737385204464
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23466.Leucine,28343,-0.0192084775754688,0.00219539011822342,-0.0235114422071867,-0.0149055129437509,2.26037101112284e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23467.Valine,28327,-0.0241103339536373,0.00220536306639067,-0.0284328455637631,-0.0197878223435116,9.14992836861433e-28
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23468.Phenylalanine,28337,0.0202200664794967,0.0020988881680427,0.016106245670133,0.0243338872888604,6.22567258398599e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23469.Tyrosine,28316,-0.00952501493979515,0.00213506234315704,-0.0137097371323829,-0.00534029274720736,8.18023839226041e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23470.Glucose,28295,0.00264567029148988,0.00211068486602473,-0.0014912720459186,0.00678261262889835,0.21004677283069
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23471.Lactate,28298,0.00562848998363117,0.00209363558772882,0.00152496423168268,0.00973201573557965,0.00718414851720531
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23472.Pyruvate,28265,0.00263186900280948,0.00208731988160956,-0.00145927796514526,0.00672301597076421,0.207360924847204
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23473.Citrate,28345,0.0384964387244116,0.00210881788268655,0.0343631556743459,0.0426297217744772,5.02297356862266e-74
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23474.3-Hydroxybutyrate,27879,-0.00349473181473193,0.00212716083916126,-0.00766396705948801,0.000674503430024145,0.100413033157937
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23475.Acetate,28325,-0.00673205874274486,0.00209296102656203,-0.0108342623548064,-0.00262985513068329,0.00129899592751723
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23476.Acetoacetate,28346,-0.0159980809713711,0.00208788383962546,-0.020090333297037,-0.0119058286457052,1.88396097042441e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23477.Acetone,28346,-0.017612094161273,0.00208647130400947,-0.0217015779171316,-0.0135226104054144,3.29179320938198e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23478.Creatinine,27649,0.131300284374704,0.00234930704804922,0.126695642560528,0.135904926188881,0
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23479.Albumin,28344,-0.0524308427461251,0.00209027665357548,-0.0565277849871331,-0.0483339005051172,2.397096047535e-137
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23480.Glycoprotein Acetyls,28347,0.0279553019474877,0.0022166993828631,0.023610571157076,0.0323000327378993,2.29355546772249e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,28347,0.0162290587551119,0.00223203100795432,0.0118542779795214,0.0206038395307024,3.6611951896582e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,28347,0.014144115478953,0.00222709842328241,0.00977900256931942,0.0185092283885865,2.17280791151622e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,28347,0.0164868407984134,0.00224200560728269,0.0120925098081394,0.0208811717886875,1.98143543124168e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,28347,0.0136563619896353,0.00222093530726169,0.00930332878740235,0.0180093951918682,7.90519072551912e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,28347,0.012838660079893,0.00221265256570553,0.00850186105111014,0.0171754591086758,6.60739880536476e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,28347,0.0143835766860063,0.00222169990925265,0.0100290448638711,0.0187381085081415,9.6918157836576e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,28347,0.0130765764078254,0.00221743675757329,0.00873040036298174,0.017422752452669,3.74005129200658e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,28347,0.0114654744129615,0.00224350035468355,0.00706821371778174,0.0158627351081412,3.23342369706966e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,28347,0.00991411862679399,0.00224057696848833,0.00552258776855688,0.0143056494850311,9.6888704657891e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,28347,0.0113453825034855,0.00222756049257262,0.0069793639380432,0.0157114010689279,3.54349033498413e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,28347,0.00591926714243703,0.00218141053328048,0.00164370249720729,0.0101948317876668,0.00666159191998108
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,28347,0.00189316328674243,0.00215247319283707,-0.00232568417121822,0.00611201074470309,0.379121801482661
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,28347,0.0101248258718757,0.00220855699395968,0.00579605416371476,0.0144535975800367,4.57317539974657e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,28347,0.0105822735559702,0.00226091803275111,0.00615087421177801,0.0150136729001624,2.87470196297253e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,28347,0.00860889206057861,0.00221632283355194,0.00426489930681682,0.0129528848143404,0.000102852600604518
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,28347,0.00579200198563598,0.00221179135639777,0.00145689092709636,0.0101271130441756,0.00883143894814101
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,28347,0.0108040776870981,0.00222397207319363,0.00644509242363863,0.0151630629505577,1.19204326049201e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,28347,0.00591185808796492,0.00217091603662852,0.00165686265617302,0.0101668535197568,0.00646907252642275
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,28347,0.00444355950450109,0.00213203613628331,0.000264768677385814,0.00862235033161637,0.0371522030216924
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,28347,0.00708982661914952,0.0022138009185509,0.00275077681878976,0.0114288764195093,0.00136363181318971
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,28347,0.00292854035381833,0.00222063276803583,-0.0014238998715319,0.00728098057916855,0.187251182241294
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,28347,-0.00998698795483216,0.00208568381004591,-0.0140749282225221,-0.00589904768714218,1.69005275691376e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,28347,-0.00728664041426482,0.00210264850476895,-0.011407831483612,-0.00316544934491768,0.000530112315395513
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,28347,-0.00996427420020181,0.00208048322508082,-0.0140420213213602,-0.00588652707904342,1.68122522979463e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,28347,-0.0194786549399426,0.00207370594235954,-0.0235431185869673,-0.0154141912929179,6.24534734732825e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,28347,-0.0234720542528614,0.00209335093348738,-0.0275750220824967,-0.0193690864232262,4.06984782118441e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,28347,-0.0130862109253971,0.00207207349593107,-0.017147474977422,-0.00902494687337217,2.7325644896663e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,28347,0.00192424506447129,0.0021811791951669,-0.00235086615805584,0.00619935628699841,0.377673970227972
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,28347,0.00696056206983857,0.00212986888812864,0.00278601904910643,0.0111351050905707,0.00108412230807046
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,28347,0.00327945285816303,0.00212244363272135,-0.000880536661970812,0.00743944237829687,0.122325816272353
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,28347,-0.00644843299594878,0.00208673491066787,-0.0105384334208578,-0.00235843257103975,0.00200213992213307
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,28347,-0.00554773842009383,0.00208151983678279,-0.0096275173001881,-0.00146795953999957,0.00769782673064876
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,28347,-0.00103941640413735,0.00209066935844302,-0.00513712834668567,0.00305829553841096,0.619073599754507
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,28347,-0.0132164449348744,0.00207096089246984,-0.0172755282841153,-0.00915736158563351,1.77730080675578e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,28347,0.015777161949363,0.00218625894716192,0.0114920944129256,0.0200622294858004,5.46783001663372e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,28347,0.000699646278388362,0.00209990206141566,-0.00341616176198634,0.00481545431876306,0.739000552578072
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,28347,0.00162507849648002,0.00210626694703389,-0.0025032047197064,0.00575336171266644,0.440390742192234
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,28347,0.00724786594072545,0.00210231133349161,0.0031273357270819,0.011368396154369,0.000566474557234125
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,28347,-0.0109480565651809,0.00213204083879461,-0.0151268566092183,-0.00676925652114346,2.83990341989877e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,28347,-0.0153423143031634,0.00214755990430439,-0.0195515317156,-0.0111330968907268,9.279533047494e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,28347,-0.000791566873320131,0.00210614954690771,-0.00491961998525924,0.00333648623861898,0.707041617826319
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,28347,0.0220171846602123,0.00215036601457942,0.0178024672716366,0.0262319020487879,1.46626968678379e-24
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23523.Concentration of IDL Particles,28347,-0.0224011158068691,0.00209035894164826,-0.0264982193324997,-0.0183040122812385,9.5945645316397e-27
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23524.Total Lipids in IDL,28347,-0.0309599929679311,0.00213940000207536,-0.0351532169719988,-0.0267667689638634,2.71196832168149e-47
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23525.Phospholipids in IDL,28347,-0.0263243907569338,0.00214414387975697,-0.0305269127612574,-0.0221218687526101,1.46763384736628e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23526.Cholesterol in IDL,28347,-0.0360563194966478,0.00214543146542479,-0.0402613651688804,-0.0318512738244152,4.45336706724481e-63
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,28347,-0.0368031506188941,0.00214410909535995,-0.0410056044457996,-0.0326006967919886,1.04823208508867e-65
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23528.Free Cholesterol in IDL,28347,-0.0329990865401637,0.00214631009083339,-0.0372058543181972,-0.0287923187621303,3.96117968449565e-53
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23529.Triglycerides in IDL,28347,0.0166006790861248,0.0021336609592014,0.0124187036060901,0.0207826545661595,7.47627397276509e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,28347,-0.0207548360186118,0.00206964656200309,-0.0248113432801379,-0.0166983287570857,1.25472531375161e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23531.Total Lipids in Large LDL,28347,-0.0337076162399714,0.00208018009776257,-0.037784769231586,-0.0296304632483568,8.66385175295729e-59
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23532.Phospholipids in Large LDL,28347,-0.0353561781395796,0.00207686890197471,-0.03942684118745,-0.0312855150917091,1.14806886078352e-64
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23533.Cholesterol in Large LDL,28347,-0.03573632269555,0.00208403139526212,-0.0398210242302637,-0.0316516211608362,1.40242250060586e-65
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,28347,-0.0346224051382518,0.00207731971841332,-0.0386939517863419,-0.0305508584901617,4.51153180006644e-62
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,28347,-0.0379948853894807,0.00210742829267837,-0.0421254448431303,-0.0338643259358311,2.92485286844427e-72
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23536.Triglycerides in Large LDL,28347,0.0106090120511276,0.00213525247899488,0.0064239171922976,0.0147941069099575,6.78638144592339e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,28347,-0.0218270823622922,0.00206852919522713,-0.0258813995849374,-0.0177727651396471,5.55788927167609e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,28347,-0.0280733426666502,0.00206394073300244,-0.032118666503335,-0.0240280188299655,5.29360355734245e-42
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,28347,-0.0291154059462208,0.00206130661622001,-0.0331555669140121,-0.0250752449784296,3.80641183155734e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,28347,-0.0300076323780336,0.00206155913090566,-0.0340482882746086,-0.0259669764814585,7.98762049106899e-48
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,28347,-0.0271770517496908,0.00206850791347403,-0.0312313272600998,-0.0231227762392817,2.58265567332693e-39
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,28347,-0.0361223942148935,0.00206230617449326,-0.0401645143169002,-0.0320802741128867,2.50086656135507e-68
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,28347,0.0113106391689361,0.00215534789913448,0.00708615728663252,0.0155351210512397,1.55109627428554e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,28347,-0.0138351437913643,0.00206992720294773,-0.0178922011091419,-0.00977808647358677,2.37012949940663e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23545.Total Lipids in Small LDL,28347,-0.024061025938664,0.00206432324217207,-0.0281070994933212,-0.0200149523840067,2.53190562442746e-31
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23546.Phospholipids in Small LDL,28347,-0.0230752365338859,0.00206349079558861,-0.0271196784932396,-0.0190307945745322,5.70436479699264e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23547.Cholesterol in Small LDL,28347,-0.0272554017367237,0.00206162431557654,-0.0312961853952537,-0.0232146180781937,8.78322480478415e-40
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,28347,-0.023889190854898,0.00206710494547972,-0.0279407165480382,-0.0198376651617577,7.9944622153853e-31
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,28347,-0.0333682656456411,0.00206441475050097,-0.037414518556623,-0.0293220127346592,1.66635685130015e-58
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23550.Triglycerides in Small LDL,28347,0.0145107136591733,0.00217696175953724,0.0102438686104803,0.0187775587078663,2.68456773837887e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,28347,-0.00688897281863445,0.00242706940856004,-0.0116460288594121,-0.00213191677785677,0.00453737822383534
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,28347,-0.00654568361585606,0.00243714596142753,-0.011322489700254,-0.00176887753145811,0.00723988081681649
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,28347,-0.00242204745966332,0.0024305926129502,-0.00718600898104571,0.00234191406171908,0.319023385477723
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,28347,-0.0144198754332258,0.00244064622615378,-0.0192035420364872,-0.00963620882996439,3.49771383524428e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,28347,-0.0188221058837191,0.00246688129783869,-0.023657193227483,-0.0139870185399553,2.42267464635066e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,28347,0.000705972704375584,0.00231871626714161,-0.00383871117922197,0.00525065658797314,0.760774327399265
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,28347,0.0237803002209268,0.0020992942453672,0.0196656835000071,0.0278949169418465,1.10772232691049e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,28347,-0.0294743973256499,0.00250615895809523,-0.0343864688835165,-0.0245623257677832,7.37215099698559e-32
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23559.Total Lipids in Large HDL,28347,-0.0293534781558669,0.00248809048956613,-0.0342301355154165,-0.0244768207963173,4.77404843811922e-32
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23560.Phospholipids in Large HDL,28347,-0.0287466076881237,0.00246006018544595,-0.0335683256515977,-0.0239248897246496,1.78920437725392e-31
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23561.Cholesterol in Large HDL,28347,-0.0327849744796611,0.00250363189270299,-0.037692092989359,-0.0278778559699633,4.5695123026256e-39
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,28347,-0.0339342078262687,0.00250345002287319,-0.0388409698711002,-0.0290274457814373,9.99193782371245e-42
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,28347,-0.0275749355473855,0.00249054852232698,-0.0324564106511464,-0.0226934604436246,1.96564011274198e-28
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23564.Triglycerides in Large HDL,28347,0.0222021104308499,0.00214867562321427,0.0179907062093499,0.0264135146523499,5.53920630314891e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,28347,-0.0450017708278037,0.0022601828320304,-0.0494317291785832,-0.0405718124770241,1.30823875720283e-87
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,28347,-0.0433869824857474,0.00223314231690065,-0.0477639414268727,-0.0390100235446222,1.54589111758084e-83
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,28347,-0.0400656122811912,0.00220991363386551,-0.0443970430035676,-0.0357341815588148,4.79054146756998e-73
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,28347,-0.0512190507354246,0.00227225531207165,-0.0556726711470851,-0.0467654303237642,1.57467733397187e-111
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,28347,-0.0518838386836838,0.00226412991101671,-0.0563215333092765,-0.047446144058091,3.62797473351288e-115
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,28347,-0.046467410225778,0.0022954581144348,-0.0509665081300701,-0.0419683123214858,1.78222940233576e-90
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,28347,0.0142775274081243,0.00213150997275189,0.0100997678615306,0.018455286954718,2.14777630656273e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,28347,-0.0506003514269008,0.00204983082779207,-0.0546180198493733,-0.0465826830044284,3.94709709016509e-133
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23573.Total Lipids in Small HDL,28347,-0.0434151999687738,0.00207012497837676,-0.0474726449263922,-0.0393577550111553,6.41641975291756e-97
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23574.Phospholipids in Small HDL,28347,-0.0411307650921276,0.00208204751423018,-0.0452115782200188,-0.0370499519642365,2.77271586770727e-86
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23575.Cholesterol in Small HDL,28347,-0.0537161013369928,0.00204786791911805,-0.0577299224584642,-0.0497022802155215,7.41077776670044e-150
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,28347,-0.0554436602627183,0.00204016824540149,-0.0594423900237053,-0.0514449305017314,1.43270245756585e-160
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,28347,-0.0406787164546009,0.00209345887494077,-0.0447818958494848,-0.036575537059717,1.46843668997287e-83
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23578.Triglycerides in Small HDL,28347,0.0182365734231554,0.00223089015996705,0.01386402870962,0.0226091181366909,3.0919146182605e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27126,0.0160842326127802,0.00212758480594728,0.0119141663931235,0.0202542988324368,4.16274311060332e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27126,-0.00624297721848162,0.00215458995805293,-0.0104659735362654,-0.00201998090069788,0.00376421415027041
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27126,-0.00606572128736022,0.00213364117080667,-0.0102476579821413,-0.00188378459257915,0.00447389676974148
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27126,-0.00490386224381805,0.00217815522880974,-0.00917304649228514,-0.000634677995350965,0.0243692458324286
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27126,0.000467648365865676,0.0021244043178388,-0.00369618409709837,0.00463148082882972,0.825770379583568
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,28047,0.0129831518086993,0.00207727544426407,0.00891169193794171,0.0170546116794569,4.16126730403969e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,28047,-0.0158586009720394,0.00226379467933097,-0.0202956385435281,-0.0114215634005507,2.51987858315112e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,28047,-0.0189452385172525,0.00225789515467954,-0.0233707130204244,-0.0145197640140806,5.05846169804911e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,28047,-0.00139090112140574,0.00219958982428538,-0.00570209717700509,0.00292029493419362,0.527166178262619
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,28047,0.00997064354345164,0.00220979712084249,0.00563944118660035,0.0143018459003029,6.44745116579793e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,28342,0.0336572632374697,0.0021920685039287,0.0293608089697694,0.0379537175051699,5.43678101523763e-53
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,28342,-0.000595223363745131,0.00213477360582297,-0.00477937963115815,0.00358893290366789,0.780382919925092
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,28342,-0.00371984201297525,0.00221285281290575,-0.00805703352627051,0.000617349500320014,0.0927707405431698
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,28342,0.00849359871482163,0.00209006417922598,0.00439707292353872,0.0125901245061045,4.84107248899108e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,28342,-0.0121760740029623,0.00206936350947648,-0.0162320264815362,-0.00812012152438843,4.05039390547054e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,28347,-0.0161852872284248,0.00218185196880635,-0.0204617170872853,-0.0119088573695644,1.22104560318007e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,28347,-0.0257489824044181,0.0022716178612342,-0.0302013534124371,-0.0212966113963991,1.01921562618643e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,28347,-0.0271301137765763,0.00228702343821678,-0.0316126797154812,-0.0226475478376715,2.20820123326233e-32
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,28347,-0.0210675077192728,0.00222200482587037,-0.0254226371779787,-0.0167123782605669,2.70064746802899e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,28347,0.023765414493602,0.00225452976600017,0.0193465361522416,0.0281842928349623,6.23169458560965e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,28347,-0.0385342740356738,0.00220502375425789,-0.0428561205940193,-0.0342124274773284,4.99690152322546e-68
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,28347,-0.02352898476205,0.00214971717820014,-0.0277424304313222,-0.0193155390927777,7.97008800395104e-28
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,28347,-0.010918323591061,0.0021027841188856,-0.0150397804640768,-0.00679686671804528,2.09125453759244e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,28347,-0.038235944597932,0.00221834597938298,-0.0425839027175227,-0.0338879864783414,3.09278284098869e-66
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,28347,0.028444629758466,0.00216796764510412,0.0241954131740619,0.0326938463428701,3.27384275373388e-39
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,28347,0.0492148667115002,0.00214269295553035,0.0450151885186608,0.0534145449043397,1.09405287748472e-115
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,28347,-0.0392999475889615,0.00224946324498429,-0.0437088955491307,-0.0348909996287923,5.43651021233009e-68
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,28347,-0.0415536250927321,0.00226961174213875,-0.0460020641073241,-0.0371051860781402,1.89767481924795e-74
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,28347,-0.0167068836626137,0.00210042014153098,-0.0208237071400144,-0.0125900601852129,1.87171427716753e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,28347,0.0325732668579617,0.00223917456508833,0.0281844847103886,0.0369620490055348,9.07529032865883e-48
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,28347,0.0384954054775404,0.00205381128537684,0.0344699353582018,0.042520875596879,6.49434019258633e-78
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,28347,-0.0496550269665501,0.00215228523087349,-0.0538735060190621,-0.045436547914038,1.08331326611845e-116
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,28347,-0.0492562248496645,0.00213518086587677,-0.053441179346783,-0.0450712703525461,1.13263265061555e-116
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,28347,-0.0215562997512753,0.00211446798105864,-0.0257006569941502,-0.0174119425084003,2.30770772906481e-24
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,28347,0.047204301220327,0.00220222625112127,0.0428879377681293,0.0515206646725247,4.02832154885915e-101
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,28347,-0.00516798869225552,0.00208192982019146,-0.00924857113983079,-0.00108740624468025,0.0130592281777093
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,28347,-0.0486018696647782,0.00219110029313153,-0.052896426239316,-0.0443073130902404,4.31931793924067e-108
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,28347,-0.0314373321646897,0.00205923435095617,-0.0354734314925638,-0.0274012328368156,2.06733515770187e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,28347,-0.0331245701071252,0.0022750546899329,-0.0375836772993937,-0.0286654629148567,7.52546724388125e-48
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,28347,0.0487535479036416,0.00216768387425288,0.044504887510106,0.0530022082971772,4.76787909506689e-111
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,28347,-0.00129039706877342,0.00208233968604761,-0.00537178285342673,0.00279098871587989,0.535469417208867
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,28347,-0.0416071235568423,0.00209284416230821,-0.0457090981149664,-0.0375051489987182,2.36113653952602e-87
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,28347,-0.00971408503611062,0.00212274008628134,-0.013874655605222,-0.0055535144669992,4.75503429467333e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,28347,-0.0305219048237739,0.0022556635246659,-0.0349430053321191,-0.0261008043154288,1.37773547878559e-41
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,28347,0.0468461411765314,0.0021262443259884,0.0426787022975941,0.0510135800554686,1.1116431701167e-106
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,28347,0.0118189800805531,0.00209158753326933,0.00771946851534517,0.0159184916457609,1.6130759967937e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,28347,-0.0401019868347029,0.00207560014799883,-0.0441701631247806,-0.0360338105446252,1.2257544609392e-82
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,28347,-0.0120740230506309,0.00209067252200417,-0.0161717411937591,-0.00797630490750276,7.76707806017277e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,28347,-0.033466713622563,0.00217599192661521,-0.0377316577987289,-0.0292017694463972,3.65901001748255e-53
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,28347,0.0395310280102342,0.00218260035116032,0.03525313132196,0.0438089246985084,6.62571066977225e-73
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,28335,0.0107155095197602,0.00233855661030213,0.00613193856356807,0.0152990804759524,4.62283081658953e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,28335,-0.0276305006294123,0.0021777309326655,-0.0318988532574367,-0.0233621480013879,8.70892186691152e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,28335,-0.0481009527168184,0.0020767167513189,-0.0521713175494035,-0.0440305878842334,1.36489611317091e-117
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,28335,0.0175613024383015,0.00245969906123778,0.0127402922782755,0.0223823125983276,9.58475104821408e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,28335,0.0253622227816048,0.00229938232601831,0.020855433422609,0.0298690121406007,3.12586962307487e-28
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,28347,0.00580066312691855,0.00229557286166258,0.00130134031805989,0.0102999859357772,0.0115131066354818
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,28347,-0.0292467116191103,0.00234895454970468,-0.0338506625365315,-0.0246427607016891,1.71170962948477e-35
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,28347,-0.0309987585003602,0.00231283435914353,-0.0355319138442816,-0.0264656031564389,7.74192542203874e-41
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,28347,-0.00867174411737816,0.002270371366839,-0.0131216719963826,-0.00422181623837373,0.000133992950322131
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,28347,0.0441136424307374,0.00225211438405314,0.0396994982379933,0.0485277866234816,7.18737884935467e-85
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,28347,0.0374847857391678,0.00231273543340006,0.0329518242897037,0.0420177471886319,8.14843864606459e-59
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,28347,-0.044024867832704,0.00227093924886949,-0.0484759087604882,-0.0395738269049198,3.49477815566334e-83
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,28347,-0.0384735704122288,0.00221198550531067,-0.0428090620026377,-0.0341380788218199,2.08129430148344e-67
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,28347,-0.0431582758717892,0.00240968336106874,-0.0478812552594839,-0.0384352964840945,2.42471158172756e-71
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,28347,0.0441921598581062,0.00221862714771093,0.0398436506485927,0.0485406690676196,1.11716941023401e-87
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,28347,0.011780052158009,0.00213748741822161,0.00759057681829464,0.0159695274977234,3.59561768504886e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,28347,-0.0368048264398954,0.00212432772223588,-0.0409685087754777,-0.0326411441043131,6.6986938491329e-67
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,28347,-0.0377137523579189,0.00210953097234567,-0.0418484330637164,-0.0335790716521214,4.32166635019312e-71
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,28347,0.00203640184176713,0.00222224793440441,-0.00231920410966551,0.00639200779319978,0.359480545617383
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,28347,0.0462797105162751,0.00225533424970177,0.0418592553868597,0.0507001656456906,6.75221272066237e-93
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48922,-0.00316499228150365,0.00176809681022223,-0.00663046202953922,0.000300477466531924,0.0734510951071914
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48922,-0.0011327415705116,0.00172542674654071,-0.00451457799373138,0.00224909485270819,0.511505962105202
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45619,-0.000672979443035324,0.00165255852100775,-0.00391199414421052,0.00256603525813987,0.683837409573385
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45619,-0.00227921957109198,0.00179834905679949,-0.00580398372241898,0.00124554458023503,0.205020365719624
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45619,-0.00475190268450456,0.00177270310966155,-0.0082264007794412,-0.00127740458956792,0.00735173709666426
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45619,-0.00138484495327429,0.00162781329343007,-0.00457535900839722,0.00180566910184864,0.394918581353361
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24009.Traffic intensity on the nearest road,48922,-0.102021957560515,0.0549382676327454,-0.209700962120696,0.00565704699966552,0.0633130324380009
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24010.Inverse distance to the nearest road,48922,0.00180824566260683,0.00154595281859408,-0.00122182186183758,0.00483831318705123,0.242141831555735
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24011.Traffic intensity on the nearest major road,48922,0.00145103587238364,0.00154493373627705,-0.00157703425071938,0.00447910599548666,0.347621374836102
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24012.Inverse distance to the nearest major road,48922,-0.00382698685313652,0.00156859661550858,-0.00690143621953334,-0.000752537486739696,0.014700872020832
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24013.Total traffic load on major roads,48922,-0.0290095373806037,0.0378282480561911,-0.103152903570738,0.0451338288095309,0.443159546121056
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24015.Sum of road length of major roads within 100m,48922,-0.0596902711778811,0.0369654325100722,-0.132142518897623,0.0127619765418605,0.106369308799081
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48922,-0.00516544974186165,0.00176449205170874,-0.00862385416321077,-0.00170704532051253,0.00341919204665087
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48922,-0.00580367747336749,0.00176209297699862,-0.00925737970828479,-0.00234997523845018,0.000989737509465219
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48922,-0.00482113894684827,0.00174382113090468,-0.00823902836342145,-0.0014032495302751,0.00569968374511735
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48821,-0.00211192026671624,0.00171386544653086,-0.00547109654191672,0.00124725600848425,0.217859561856081
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24020.Average daytime sound level of noise pollution,48922,-0.00126309053270235,0.00155096004722593,-0.00430297222526517,0.00177679115986046,0.41542398734536
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24021.Average evening sound level of noise pollution,48922,-0.00123902263879613,0.00155089654347935,-0.00427877986401566,0.00180073458642339,0.424348019623181
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24022.Average night-time sound level of noise pollution,48922,-0.00126882359847047,0.00155095865449624,-0.00430870256128309,0.00177105536434216,0.413309845679888
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48922,-0.00125025074812408,0.00155089593745836,-0.00429000678554247,0.0017895052892943,0.420161775572641
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48922,-0.00124338215127538,0.0015508978161725,-0.00428314187097347,0.00179637756842271,0.422720199293037
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2405.Number of children fathered,22516,-0.155920637768215,0.0409842127862201,-0.236249694829206,-0.0755915807072233,0.000142520012941326
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",43647,0.00532000304660489,0.001816465011398,0.00175973162426482,0.00888027446894497,0.00340485230501171
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",43647,6.13018321258781e-05,0.0016457372758108,-0.00316434322846329,0.00328694689271505,0.970286753924741
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24502.Water percentage, buffer 1000m",43647,-0.0013099204977276,0.00163600093513312,-0.00451648233058852,0.00189664133513332,0.423318710546025
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",43647,0.00337360906709347,0.00170856693009418,2.48178841088793e-05,0.00672240025007806,0.0483283097839388
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",43647,0.00108144481741629,0.0016592181275957,-0.00217062271267128,0.00433351234750387,0.514546683871847
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24505.Water percentage, buffer 300m",43647,-0.000920828966216439,0.00164650350435199,-0.00414797583474634,0.00230631790231346,0.575984915729156
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",49152,0.00403345862151452,0.00173738762191764,0.000628178882555935,0.0074387383604731,0.0202604282129578
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",49152,0.000362389656642241,0.00163315290281937,-0.00283859003288372,0.0035633693461682,0.824395976266144
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24508.Distance (Euclidean) to coast,49152,0.003630192608825,0.00155410357589917,0.000584149600062627,0.00667623561758737,0.0195017267150317
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,10811,0.0581848669115538,0.0563250968857094,-0.0522123229844366,0.168582056807544,0.301618380304785
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2704.Years since last cervical smear test,20368,0.0144770800988062,0.0409793578127417,-0.0658424612141675,0.0947966214117799,0.723884161577453
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2714.Age when periods started (menarche),25934,0.0808458467014242,0.0349670166061945,0.0123104941532829,0.149381199249565,0.0207821646843354
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2734.Number of live births,26733,-0.0734353021848039,0.0335433608096945,-0.139180289371805,-0.00769031499780272,0.0285862148090216
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2744.Birth weight of first child,21208,-0.203693936859566,0.0370192223090017,-0.276251612585209,-0.131136261133923,3.79030068693763e-08
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2754.Age at first live birth,18053,-0.015389713944257,0.00262494622578363,-0.0205346085467929,-0.0102448193417211,4.62874993502703e-09
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2764.Age at last live birth,18006,-0.0125240151728573,0.00253572593350298,-0.0174940380025231,-0.00755399234319145,7.92180012175044e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2794.Age started oral contraceptive pill,20506,0.006410002427437,0.00280296925256264,0.000916182692414233,0.0119038221624598,0.0222140575548633
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2804.Age when last used oral contraceptive pill,18601,-0.00411439724614695,0.00242935652074392,-0.00887593602680503,0.000647141534511133,0.0903550167493939
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2867.Age started smoking in former smokers,12084,-0.0121619687547248,0.0033024051965891,-0.0186346829400394,-0.00568925456941017,0.000231728723123065
EPHA2,Ephrin type-A receptor 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",18808,0.0121353983926957,0.05374076623354,-0.0931965034250426,0.117467300210434,0.821348818503654
EPHA2,Ephrin type-A receptor 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,18800,0.0523587975865242,0.0591772539353124,-0.063628620126688,0.168346215299736,0.376287107949024
EPHA2,Ephrin type-A receptor 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,18838,0.122825173293861,0.0607108701734861,0.00383186775382779,0.241818478833893,0.0430752276947567
EPHA2,Ephrin type-A receptor 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",18782,0.146990789262651,0.0593849316645351,0.030596323200162,0.26338525532514,0.0133241640304934
EPHA2,Ephrin type-A receptor 2,Mental health,X28739.Difficulty with standing for long periods,18856,0.435907766258432,0.051516825035376,0.334934789189095,0.536880743327769,2.83112052910494e-17
EPHA2,Ephrin type-A receptor 2,Mental health,X28740.Difficulty with taking care of household responsibilities,18902,0.361767898811703,0.0569892373571229,0.250068993591742,0.473466804031664,2.23094751967491e-10
EPHA2,Ephrin type-A receptor 2,Mental health,X28741.Difficulty learning a new task,18754,0.156143698720816,0.0649630264724432,0.028816166834827,0.283471230606804,0.0162451570883745
EPHA2,Ephrin type-A receptor 2,Mental health,X28742.Difficulty with joining in community activities,18069,0.246687754978773,0.0654580146860617,0.118390046194092,0.374985463763453,0.0001646610158312
EPHA2,Ephrin type-A receptor 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,18775,0.241660671207821,0.0553625076710949,0.133150156172475,0.350171186243167,1.27767477728328e-05
EPHA2,Ephrin type-A receptor 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,18901,0.306132476678373,0.0779259919286763,0.153397532498167,0.458867420858578,8.57804563915207e-05
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,11485,0.105780199214798,0.0528415558537213,0.00221074974150474,0.209349648688092,0.04532573577539
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2897.Age stopped smoking,12087,0.0193795479470904,0.00344653456118319,0.0126243402071713,0.0261347556870094,1.91937107928134e-08
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,16892,-0.000933461954760741,0.00501389033837445,-0.0107606870179747,0.00889376310845319,0.852309621691967
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,16892,0.00260904465845748,0.00546347471647747,-0.00809936578583836,0.0133174551027533,0.632981620736399
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,16892,0.000278397180626723,0.0180895630073905,-0.0351771463138586,0.0357339406751121,0.987721275892679
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,16892,-0.0062120467504308,0.0186665913250362,-0.0427985657475018,0.0303744722466402,0.739297271186282
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,16892,0.0155849036635534,0.0206534909967109,-0.0248959386899999,0.0560657460171066,0.450505963840694
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,16892,-0.0241538936135221,0.0177148774508597,-0.0588750534172072,0.0105672661901629,0.172749246948622
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,16892,-0.0066758421014991,0.00787611195610433,-0.0221130215354636,0.0087613373324654,0.396669284634586
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,16892,0.00549237443204638,0.014254182143064,-0.0224458225683591,0.0334305714324519,0.700007645472498
EPHA2,Ephrin type-A receptor 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,16778,0.0762264682559553,0.0623024941707502,-0.0458864203187152,0.198339356830626,0.221161940393194
EPHA2,Ephrin type-A receptor 2,Mental health,X29003.Recent feelings of depression,16764,0.166231033744572,0.0601117451621685,0.0484120132267214,0.284050054262422,0.00569210350719813
EPHA2,Ephrin type-A receptor 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",16786,0.0333846481019749,0.0487972248490481,-0.0622579126021593,0.129027208806109,0.493889559432803
EPHA2,Ephrin type-A receptor 2,Mental health,X29005.Recent feelings of tiredness or low energy,16795,0.153911405194599,0.0489454622797522,0.0579782991262845,0.249844511262913,0.00166633211087075
EPHA2,Ephrin type-A receptor 2,Mental health,X29006.Recent poor appetite or overeating,16809,0.195516778557806,0.0679210058070081,0.06239160717607,0.328641949939542,0.0039996050078045
EPHA2,Ephrin type-A receptor 2,Mental health,X29007.Recent feelings of inadequacy,16738,0.177093652975455,0.0654435614168897,0.0488242725983506,0.305363033352558,0.00681575221253125
EPHA2,Ephrin type-A receptor 2,Mental health,X29008.Recent trouble concentrating on things,16805,0.0384001444727112,0.0650499344431252,-0.0890977270358142,0.165898015981237,0.554985447307267
EPHA2,Ephrin type-A receptor 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,16789,0.262125248984438,0.111168727880094,0.044234542339453,0.480015955629423,0.0183898322377495
EPHA2,Ephrin type-A receptor 2,Mental health,X29010.Recent thoughts of suicide or self-harm,16704,0.419529602294424,0.121888768370081,0.180627616289066,0.658431588299783,0.000579047880510987
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#0.Substances taken for depression_None of options listed,15472,-0.0160682915658448,0.0108263647088508,-0.0372879663951923,0.00515138326350265,0.137781132692723
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),15472,-0.0356238323063122,0.021030292894577,-0.0768432063796832,0.00559554176705872,0.0902988372217798
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),15472,-0.0150139333753732,0.0107535626994989,-0.036090916266391,0.00606304951564458,0.162679669213196
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),15472,0.0112061438725823,0.0309884562104237,-0.0495312302998483,0.0719435180450128,0.717638587825277
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),15472,-0.00914920801620648,0.020116867208083,-0.0485782677440492,0.0302798517116362,0.649257485196361
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),15472,0.0160997769586938,0.0213875453588067,-0.0258198119445673,0.0580193658619549,0.451603128920887
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),15472,0.0209588456023617,0.0241708479298701,-0.0264160163401837,0.0683337075449072,0.385893804090414
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),15472,0.00269661555781625,0.0281895048522656,-0.0525548139526244,0.0579480450682569,0.92379163855674
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),15472,0.012667377617365,0.0209880962832826,-0.0284692910978688,0.0538040463325988,0.54615133606278
EPHA2,Ephrin type-A receptor 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,15472,-0.0247673500977702,0.0106170343659307,-0.0455767374549942,-0.00395796274054609,0.0196717427058392
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,15472,-0.0142308454416009,0.016447611860496,-0.0464681646881731,0.0180064738049713,0.386930052320163
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,15472,-0.0589025639972819,0.0259063857360514,-0.109679080039943,-0.00812604795462116,0.022999505690418
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,15472,-0.0308749645536688,0.0331748701746726,-0.0958977100960272,0.0341477809886896,0.352037140021446
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,15472,-0.0257383379119309,0.0210854205398866,-0.0670657621701087,0.0155890863462468,0.222229652996079
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,15472,0.0123162526289274,0.0342899669675317,-0.0548920826274347,0.0795245878852896,0.719465729569357
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,15472,-0.0186222922229069,0.0331764570794136,-0.0836481480985577,0.0464035636527438,0.57459405231656
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,15472,0.00579404811765226,0.0178309659611835,-0.0291546451662675,0.040742741401572,0.745228586200531
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,15472,-0.0109474199738561,0.0175032060411396,-0.0452537038144897,0.0233588638667775,0.531683497760847
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,15472,-0.0146140229032394,0.0247723472804712,-0.0631678235729629,0.0339397777664842,0.555244252545972
EPHA2,Ephrin type-A receptor 2,Mental health,X29058.Recent feelings or nervousness or anxiety,16539,0.0732992277783275,0.0568352546311521,-0.0380978712987305,0.184696326855386,0.197180225242118
EPHA2,Ephrin type-A receptor 2,Mental health,X29059.Recent inability to stop or control worrying,16557,0.0883061971569956,0.0588212801107258,-0.0269835118600269,0.203595906174018,0.133306701442897
EPHA2,Ephrin type-A receptor 2,Mental health,X29060.Recent worrying too much about different things,16546,0.0619817013571574,0.054351091526806,-0.0445464380353824,0.168509840749697,0.254138386965761
EPHA2,Ephrin type-A receptor 2,Mental health,X29061.Recent trouble relaxing,16551,0.0976448893707325,0.0577168571522618,-0.0154801506477007,0.210769929389166,0.0907045740692564
EPHA2,Ephrin type-A receptor 2,Mental health,X29062.Recent restlessness,16569,0.184748122976326,0.0812402061278409,0.025517318965758,0.343978926986894,0.0229728873450906
EPHA2,Ephrin type-A receptor 2,Mental health,X29063.Recent easy annoyance or irritability,16521,0.0802017720010152,0.0584318702615339,-0.0343246937115912,0.194728237713622,0.169905034128256
EPHA2,Ephrin type-A receptor 2,Mental health,X29064.Recent feelings of foreboding,16517,0.0993177239261675,0.066580631726415,-0.0311803142576059,0.229815762109941,0.135799306559487
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,15472,-0.0235741883892186,0.0113285538414492,-0.0457781539184591,-0.00137022285997815,0.0374546283946998
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,15472,-0.0235114323960846,0.018758044362061,-0.0602771993457241,0.0132543345535549,0.210077197399564
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',15472,-0.0340768740913807,0.0243671917496869,-0.0818365699207669,0.0136828217380056,0.161990959681272
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,15472,-0.0168868251938643,0.025902078523439,-0.0676548990998047,0.0338812487120761,0.514443990519571
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,15472,-0.00586547183550376,0.0172851343273686,-0.0397443351171461,0.0280133914461386,0.734361083253817
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,15472,-0.013933832971261,0.0184363422641419,-0.0500690638089791,0.022201397866457,0.449792163837307
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,15472,-0.0240320996052701,0.0184587343080262,-0.0602112188490014,0.0121470196384612,0.192957499922943
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,15472,-0.0129925787790243,0.0171956161104141,-0.046695986355436,0.0207108287973873,0.449915522678959
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,15472,-0.0203615581109487,0.0227795435418459,-0.0650094634529666,0.0242863472310693,0.371414586291321
EPHA2,Ephrin type-A receptor 2,Mental health,X29076.Felt loved as a child,16486,-0.0813243230882269,0.0505874403522639,-0.180475706178664,0.0178270600022103,0.107942181107983
EPHA2,Ephrin type-A receptor 2,Mental health,X29077.Physically abused by family as a child,16513,0.0652939126488833,0.0685937951233461,-0.069149925792875,0.199737751090642,0.341165498157339
EPHA2,Ephrin type-A receptor 2,Mental health,X29078.Felt hated by family member as a child,16485,0.247915542960159,0.068584595254672,0.113489736261002,0.382341349659317,0.000301544725942431
EPHA2,Ephrin type-A receptor 2,Mental health,X29079.Sexually molested as a child,16367,-0.000689488782739377,0.0925953739629462,-0.182176421750114,0.180797444184635,0.994058893708479
EPHA2,Ephrin type-A receptor 2,Mental health,X29080.Someone to take to doctor when needed as a child,16453,-0.0297187801663099,0.0736342566898482,-0.174041923278412,0.114604362945793,0.68651219443755
EPHA2,Ephrin type-A receptor 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,16488,-0.0658507523570735,0.0971769824346853,-0.256317637929057,0.12461613321491,0.49801117862805
EPHA2,Ephrin type-A receptor 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,16387,0.102681110927057,0.0748106231980014,-0.0439477105410261,0.24930993239514,0.169911959502243
EPHA2,Ephrin type-A receptor 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,16501,-0.0183840143481219,0.0849484349270907,-0.18488294680522,0.148114918108976,0.828667881146019
EPHA2,Ephrin type-A receptor 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,16454,0.0727853248145056,0.118046257602942,-0.158585340087261,0.304155989716272,0.537518297501864
EPHA2,Ephrin type-A receptor 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,16451,-0.0475433085609934,0.113959524837177,-0.270903977241861,0.175817360119874,0.676541458257503
EPHA2,Ephrin type-A receptor 2,Mental health,X29086.Experienced a violent or sexual assault,16503,0.0761393102230119,0.0960757564390277,-0.112169172397482,0.264447792843506,0.428085002946181
EPHA2,Ephrin type-A receptor 2,Mental health,X29087.Experienced a life-threatening injury or illness,16504,0.32817470951475,0.058742030700491,0.213040329341787,0.443309089687712,2.35069432392914e-08
EPHA2,Ephrin type-A receptor 2,Mental health,X29088.Experienced a marital separation or divorce,16511,-0.109237370902984,0.0558496400628503,-0.21870266542617,0.000227923620202811,0.0504915529420227
EPHA2,Ephrin type-A receptor 2,Mental health,X29089.Experienced the death of a spouse or partner,16528,0.107594189374709,0.0738145245454519,-0.0370822787343766,0.252270657483795,0.144961856594393
EPHA2,Ephrin type-A receptor 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,16505,0.0415140343637258,0.0694156562389978,-0.0945406518647099,0.177568720592162,0.5498147734461
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29091.Frequency of drinking alcohol,16514,-0.773064255564636,0.046545710168759,-0.864293847495403,-0.681834663633868,1.90113044871296e-61
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,14717,-0.662454498322083,0.0549752676209605,-0.770206022859166,-0.554702973785001,2.78152827305484e-33
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,14756,-0.740116548768449,0.0558114985189046,-0.849507085865501,-0.630726011671396,6.59538752566624e-40
EPHA2,Ephrin type-A receptor 2,Mental health,X29104.Ever used cannabis,16504,-0.264954846858827,0.0680053476812788,-0.398245328314133,-0.13166436540352,9.81448538979208e-05
EPHA2,Ephrin type-A receptor 2,Mental health,X29108.Ever thought that life not worth living,16423,0.142446469813838,0.0577200563576468,0.0293151593528501,0.255577780274826,0.0136015161425932
EPHA2,Ephrin type-A receptor 2,Mental health,X29109.Ever contemplated self-harm,16464,0.168055095401351,0.0783167247530078,0.0145543148854552,0.321555875917246,0.0319004016065389
EPHA2,Ephrin type-A receptor 2,Mental health,X29111.Ever self-harmed,16492,0.196084100780492,0.126912190022615,-0.0526637916638328,0.444831993224817,0.122356382565679
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,16486,0.190003181595623,0.0829358032118899,0.0274490073003188,0.352557355890927,0.0219778957014896
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,16764,-0.0106239079453962,0.0238097278841834,-0.0572909745983957,0.0360431587076032,0.655458327375357
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,16764,-0.0241582081164118,0.0185219297116049,-0.0604611903511573,0.0121447741183337,0.192148221539252
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,16764,-0.0323433287127295,0.0197572618271697,-0.0710675618939821,0.0063809044685231,0.10164194650863
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,16764,-0.026259926671451,0.0266591570068664,-0.0785118744049092,0.0259920210620073,0.324626193279967
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,16472,-0.0267285936830229,0.0519800317461703,-0.128609455905517,0.0751522685394708,0.6071128675468
EPHA2,Ephrin type-A receptor 2,Health and medical history,X29153.Pain or discomfort today,16496,0.186715482590133,0.0489119666410443,0.0908480279736859,0.282582937206579,0.000135370723954374
EPHA2,Ephrin type-A receptor 2,Mental health,X29154.Anxiety or depression today,16496,0.113907877917761,0.0606862857661276,-0.00503724218384886,0.232852998019371,0.0605363804054976
EPHA2,Ephrin type-A receptor 2,Mental health,X29166.Frequency of confiding in someone close,16088,-0.131347821563266,0.0478516955264085,-0.225137144795026,-0.037558498331505,0.00605977201961512
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,16447,0.0100187781449185,0.00507645662483295,6.89231602459227e-05,0.0199686331295911,0.0484465846831311
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,16447,-0.00787400991872748,0.00509822347964017,-0.0178665279388222,0.00211850810136727,0.122495825494202
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,16447,-0.0499925942925103,0.00635762900215112,-0.0624535471367265,-0.0375316414482941,3.96908991175964e-15
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,16447,0.0225570824510707,0.00688547535350159,0.0090615507582076,0.0360526141439338,0.00105492300510958
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,16447,0.000633066181599861,0.0111488659255695,-0.0212187110325164,0.0224848433957161,0.954718737354225
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,16447,0.00494409273166406,0.00526039493869063,-0.00536628134816956,0.0152544668114977,0.347297541088161
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,16442,-0.000158225302212075,0.00572795461746301,-0.0113850163524396,0.0110685657480154,0.977962892715876
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,16442,-0.0159460369747034,0.00838257435398528,-0.0323758827085145,0.000483808759107789,0.057151508428873
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,16442,-0.0351826794908855,0.0129653327549697,-0.0605947316906261,-0.00977062729114503,0.00666266109877554
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,16442,0.0338445213864631,0.0115806038670887,0.0111465378069692,0.0565425049659569,0.00347687017712945
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,16442,-0.00138227803923512,0.0172770158492806,-0.0352452291038251,0.0324806730253548,0.936232855028625
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,16442,0.0121884870893856,0.00823300868321342,-0.00394820992971264,0.0283251841084839,0.138774659370081
EPHA2,Ephrin type-A receptor 2,Mental health,X29171.Frequency of feeling 'in tune' with people,16160,-0.186909614423977,0.0592485514471231,-0.303036775260338,-0.0707824535876155,0.00160974626564686
EPHA2,Ephrin type-A receptor 2,Mental health,X29172.Freuency of feeling that lacks companionship,16376,0.205904626547807,0.0537733761847063,0.100508809225783,0.311300443869831,0.000129082541413304
EPHA2,Ephrin type-A receptor 2,Mental health,X29173.Frequency of feeling left out,16292,0.165660952047252,0.0561039821184048,0.055697147095179,0.275624756999326,0.00315408235782218
EPHA2,Ephrin type-A receptor 2,Mental health,X29174.Frequency of feeling isolated from others,16356,0.151455237483609,0.0579655697920152,0.0378427206912591,0.265067754275959,0.00898733732877839
EPHA2,Ephrin type-A receptor 2,Mental health,X29175.Tendency to bounce back quickly after hard times,16475,-0.0734707395106521,0.0481273058398147,-0.167800258956689,0.0208587799353847,0.126881820223808
EPHA2,Ephrin type-A receptor 2,Mental health,X29176.Ability to make it through stressful events,16475,0.0982940295218265,0.0466150550773613,0.00692852157019823,0.189659537473455,0.0349913681321842
EPHA2,Ephrin type-A receptor 2,Mental health,X29177.Quick recovery from stressful events,16475,-0.0955866069170233,0.0475000280328793,-0.188686661861467,-0.00248655197257976,0.0441994805460558
EPHA2,Ephrin type-A receptor 2,Mental health,X29178.Hard to snap back when something bad happens,16475,0.0853107455261161,0.0468156782667191,-0.00644798387665334,0.177069474928886,0.0684323621418348
EPHA2,Ephrin type-A receptor 2,Mental health,X29179.Comes through difficult times with little trouble,16475,-0.0798410069892244,0.0474495459736999,-0.172842117097676,0.0131601031192275,0.0924617185767479
EPHA2,Ephrin type-A receptor 2,Mental health,X29180.Tendency to take a long time to get over setbacks,16475,0.113546752261936,0.0471529567357893,0.0211269570597888,0.205966547464083,0.0160488409583715
EPHA2,Ephrin type-A receptor 2,Mental health,X29181.General happiness,16384,0.10563505705388,0.0488557651782067,0.00987775730459439,0.201392356803165,0.0306185917016158
EPHA2,Ephrin type-A receptor 2,Mental health,X29182.Belief that own life is meaningful,16193,-0.100505670411712,0.0485170793194135,-0.195599145877762,-0.00541219494566099,0.0383230200107995
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11009,-0.00402644950175126,0.0499972608343666,-0.10202108073711,0.0939681817336072,0.935814497474288
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2946.Father's age,10801,-0.0106393107708281,0.00465258430538002,-0.0197583760093729,-0.00152024553228325,0.0222295316041706
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2966.Age high blood pressure diagnosed,12400,-0.0330565732066113,0.00438178743478972,-0.0416448765787991,-0.0244682698344234,4.87260311070237e-14
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,48031,0.010352068059034,0.00164276221136742,0.00713225412475381,0.0135718819933141,2.97093364626417e-10
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48032,-0.0258976568650628,0.0018295965463394,-0.0294836660958881,-0.0223116476342376,2.15162639897415e-45
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30020.Haemoglobin concentration,48032,-0.048881492262769,0.00194946599110577,-0.0527024456053363,-0.0450605389202017,7.34512310517111e-138
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30030.Haematocrit percentage,48032,-0.040457338194902,0.00190844722474341,-0.0441978947553991,-0.0367167816344049,2.7813863071084e-99
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30040.Mean corpuscular volume,48032,-0.0132374064193748,0.00161921276611124,-0.0164110634409528,-0.0100637493977968,3.02499370965307e-16
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48031,-0.0202112398486889,0.00162120836518856,-0.0233888082444585,-0.0170336714529193,1.28679245367894e-35
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48031,-0.0172936441601351,0.00158140429600603,-0.0203931965803069,-0.0141940917399633,8.39805804606001e-28
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48032,0.0398416271663195,0.0015738620322525,0.0367568575831046,0.0429263967495344,1.85060820256895e-140
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30080.Platelet count,48032,-0.0149091803225466,0.00161923227040922,-0.0180828755725487,-0.0117354850725446,3.46627757478063e-20
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30090.Platelet crit,48032,-0.0109647490398792,0.00165376817608007,-0.0142061346649962,-0.00772336341476231,3.3886329359068e-11
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48032,0.0105899391190189,0.00155598404817718,0.00754021038459165,0.0136396678534462,1.015647889983e-11
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30110.Platelet distribution width,48032,0.00578809704532291,0.00157347169140156,0.00270409253017585,0.00887210156046997,0.000234818105326343
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30120.Lymphocyte count,47957,-0.0128349725397606,0.00161527641110731,-0.0160009143055309,-0.00966903077399022,1.9681523909483e-15
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30130.Monocyte count,47957,0.0141412152728899,0.0016271084794884,0.0109520826530926,0.0173303478926871,3.70359029976002e-18
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30140.Neutrophill count,47957,0.0108589954528058,0.00162441421434108,0.00767514359269723,0.0140428473129143,2.33657743826722e-11
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30150.Eosinophill count,47957,0.025666117057119,0.00157677320692326,0.0225756415715494,0.0287565925426886,2.05486781195525e-59
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30160.Basophill count,47957,0.029828167505388,0.0274004230427667,-0.0238766616584346,0.0835329966692107,0.276334710530963
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30170.Nucleated red blood cell count,47957,0.258325257128384,0.119028841425603,0.0250287279342027,0.491621786322566,0.0299909512654963
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30180.Lymphocyte percentage,47958,-0.0201791820858444,0.00158763989040253,-0.0232909562710334,-0.0170674079006555,5.95678223325889e-37
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30190.Monocyte percentage,47958,0.00785991145738017,0.0016097763829036,0.00470474974688912,0.0110150731678712,1.05026717167551e-06
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30200.Neutrophill percentage,47958,0.00874372308666326,0.00157439482000294,0.0056579092394575,0.011829536933869,2.81158104081784e-08
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30210.Eosinophill percentage,47958,0.0225766902825423,0.00156088448967989,0.0195173566827698,0.0256360238823149,2.57249884313609e-47
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30220.Basophill percentage,47958,0.000963835983148747,0.00155457562038331,-0.00208313223280253,0.00401080419910003,0.535261115351752
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47957,0.262760831197426,0.118991823399673,0.0295368573340671,0.495984805060784,0.0272332416066188
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30240.Reticulocyte percentage,47178,0.00295734586097278,0.00168148927181076,-0.000338373111776304,0.00625306483372187,0.0786237764042605
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30250.Reticulocyte count,47178,-0.00281777390255978,0.00171753987959462,-0.00618415206656523,0.000548604261445669,0.100889806896059
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30260.Mean reticulocyte volume,47178,0.0135056058895233,0.00159952745437157,0.010370532078955,0.0166406797000916,3.16620387014885e-17
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30270.Mean sphered cell volume,47178,-0.00370232559145542,0.00161518607109915,-0.00686809029080976,-0.000536560892101074,0.0218986280114154
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30280.Immature reticulocyte fraction,47178,0.00907693706381112,0.00167875869269446,0.00578657002612998,0.0123673041014923,6.44235211081534e-08
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47178,0.00600763319593138,0.00171611247630477,0.00264405274237402,0.00937121364948873,0.000464427428316666
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30300.High light scatter reticulocyte count,47178,0.00134265441079665,0.00174221411396279,-0.00207208525257043,0.00475739407416372,0.440912455777553
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30500.Microalbumin in urine,15631,0.0686039274098994,0.00311116600095699,0.0625060420480237,0.0747018127717751,3.87943308948136e-106
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48115,0.00398650904823506,0.00169339348322313,0.000667457821117725,0.00730556027535239,0.0185689158889257
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30520.Potassium in urine,48023,-0.0150625723547805,0.00157615493401844,-0.0181518360254566,-0.0119733086841043,1.27289488247213e-21
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30530.Sodium in urine,48007,-0.00811543076123924,0.00164984996485761,-0.0113491366923601,-0.00488172483011833,8.73236864347486e-07
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30600.Albumin,43257,-0.0676015770235448,0.00167473267624556,-0.0708840530689861,-0.0643191009781035,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30610.Alkaline phosphatase,47231,0.0691951098204503,0.00160359357195834,0.0660520664194119,0.0723381532214886,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30620.Alanine aminotransferase,47230,-0.00132798127954275,0.00172988149971816,-0.00471854901899034,0.00206258645990484,0.442686020841171
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30630.Apolipoprotein A,42981,-0.0360185723192801,0.00186145904370285,-0.0396670320449377,-0.0323701125936225,4.63816390369369e-83
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30640.Apolipoprotein B,46975,-0.0248665603228272,0.00157920744800109,-0.0279618069209094,-0.0217713137247451,1.01278198149438e-55
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30650.Aspartate aminotransferase,47091,0.0200585499018575,0.00163834776942789,0.0168473882737789,0.0232697115299362,2.0621865278046e-34
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30660.Direct bilirubin,40110,0.00177577794571485,0.00176981716960051,-0.00169306370670215,0.00524461959813186,0.315689384181668
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30670.Urea,47210,0.070692301070532,0.00164134527672731,0.0674752643281465,0.0739093378129176,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30680.Calcium,43253,-0.0243308140421859,0.00165142868455748,-0.0275676142639185,-0.0210940138204532,5.19024750412116e-49
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30690.Cholesterol,47243,-0.0302931193004223,0.00160082307475598,-0.033430732526944,-0.0271555060739006,1.44143647217287e-79
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30700.Creatinine,47224,0.136124339562328,0.001839813897163,0.132518304323888,0.139730374800767,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30710.C-reactive protein,47102,0.0232152253340623,0.00176872164252285,0.0197485309147175,0.0266819197534071,2.76035260966074e-39
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30720.Cystatin C,47242,0.211371975176042,0.00157645877603788,0.208282115975008,0.214461834377076,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30730.Gamma glutamyltransferase,47222,-0.0078258433357502,0.001759799236037,-0.0112750498383827,-0.00437663683311767,8.72725442031366e-06
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30740.Glucose,43204,-0.00267599200112812,0.00170112724815848,-0.00601020140751873,0.000658217405262495,0.115709967969633
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46983,0.0160902948080941,0.00170711989884548,0.0127443398063569,0.0194362498098312,4.47230979286548e-21
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30760.HDL cholesterol,43227,-0.0437749535084418,0.00193861079519571,-0.0475746306670254,-0.0399752763498582,3.00905377446705e-112
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30770.IGF-1,46995,-0.00585820487576362,0.00165767554523719,-0.00910724894442851,-0.00260916080709873,0.000409733213028383
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30780.LDL direct,47141,-0.0250865941616503,0.00158246224055728,-0.0281882201531426,-0.0219849681701581,1.87984851303905e-56
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30790.Lipoprotein A,37735,-0.00186935308195493,0.0017539886592007,-0.0053071708539883,0.00156846469007844,0.28653326407914
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30810.Phosphate,43152,0.0107326306985444,0.0017143539815833,0.0073724968946411,0.0140927645024476,3.87467857010212e-10
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30830.SHBG,42848,0.0371981497520972,0.0019620887497787,0.033352455802531,0.0410438437016635,7.99381647187525e-80
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30840.Total bilirubin,47057,-0.0130995255101441,0.00168357159822481,-0.0163993258426647,-0.00979972517762344,7.35334182188402e-15
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30850.Testosterone,42653,-0.00427033102275794,0.00274158555415698,-0.00964383870890562,0.00110317666338973,0.119332287782216
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30860.Total protein,43220,-0.034444153499055,0.0016724884333071,-0.0377222308283369,-0.031166076169773,8.67995007718454e-94
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30870.Triglycerides,47209,0.0145049236105953,0.00172310790162205,0.0111276321234161,0.0178822150977745,3.93959046965207e-17
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30880.Urate,47179,0.0484149320671516,0.00197034774799878,0.044553050481074,0.0522768136532292,1.73070863793914e-132
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30890.Vitamin D,45108,-0.00284258337194018,0.00178676029637805,-0.00634463355284116,0.0006594668089608,0.111635764596638
EPHA2,Ephrin type-A receptor 2,Physical measures,X3137.Number of measurements made,44901,0.0607099200406736,0.032354183141341,-0.00270427891635466,0.124124118997702,0.0606046064292605
EPHA2,Ephrin type-A receptor 2,Physical measures,X3143.Ankle spacing width,28066,0.0193324101307242,0.00282126416070704,0.0138027323757384,0.02486208788571,7.41257316314218e-12
EPHA2,Ephrin type-A receptor 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",28064,-0.0134840794779759,0.00217745091831881,-0.0177518832778807,-0.00921627567807099,6.00008998531777e-10
EPHA2,Ephrin type-A receptor 2,Physical measures,X3146.Speed of sound through heel,28066,-0.0192369323561501,0.00210128687227312,-0.0233554546258054,-0.0151184100864948,5.80373050167849e-20
EPHA2,Ephrin type-A receptor 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",28066,-0.0176996068048568,0.00212398019519754,-0.021862607987444,-0.0135366056222697,8.2218546369023e-17
EPHA2,Ephrin type-A receptor 2,Physical measures,X3148.Heel bone mineral density (BMD),28045,-0.0176604314154606,0.00212597186580293,-0.0218273362724343,-0.0134935265584868,1.02535069744287e-16
EPHA2,Ephrin type-A receptor 2,Health and medical history,X3526.Mother's age at death,29586,-0.00631185677307645,0.0021243368825072,-0.0104755570627906,-0.00214815648336234,0.00296864746486468
EPHA2,Ephrin type-A receptor 2,Health and medical history,X3581.Age at menopause (last menstrual period),15325,-0.0114169182465307,0.00281168494847104,-0.0169278207455339,-0.00590601574752745,4.92059856249082e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",9783,0.00281854585572974,0.00344438882428655,-0.0039324562398719,0.00956954795133138,0.413205454222486
EPHA2,Ephrin type-A receptor 2,Physical measures,X4100.Ankle spacing width (left),15974,0.0126022286504166,0.00370707570081254,0.00533636027682396,0.0198680970240091,0.000676727131953007
EPHA2,Ephrin type-A receptor 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),15970,-0.0105043875251709,0.00286166343107227,-0.0161132478500725,-0.00489552720026926,0.000242649440397445
EPHA2,Ephrin type-A receptor 2,Physical measures,X4103.Speed of sound through heel (left),15974,-0.0182282751204714,0.00276430142232313,-0.0236463059082248,-0.0128102443327181,4.41064974608894e-11
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",15974,-0.0159461625973785,0.00279433856459132,-0.0214230661839775,-0.0104692590107795,1.17303592554847e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),15963,-0.0157776561081345,0.00279573273358998,-0.0212572922659709,-0.0102980199502982,1.69483001214124e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",15974,-0.0159406008815475,0.00279434378660845,-0.0214175147033,-0.0104636870597949,1.18687060127093e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X4119.Ankle spacing width (right),15964,0.0129967828897095,0.00365289646357684,0.00583710582109892,0.0201564599583201,0.000374860695206097
EPHA2,Ephrin type-A receptor 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),15963,-0.0125389473411679,0.0028737921283322,-0.018171579912699,-0.00690631476963679,1.28975218665949e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X4122.Speed of sound through heel (right),15964,-0.0189677972797463,0.00276986033667314,-0.0243967235396257,-0.013538871019867,7.76638667296585e-12
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",15964,-0.0171512161926915,0.00280177234560256,-0.0226426899900725,-0.0116597423953105,9.4832791574724e-10
EPHA2,Ephrin type-A receptor 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),15951,-0.0176062337187854,0.002804579029634,-0.0231032086168681,-0.0121092588207028,3.52567019186834e-10
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",15964,-0.0171495108712657,0.00280177570483836,-0.0226409912527489,-0.0116580304897825,9.51993120699181e-10
EPHA2,Ephrin type-A receptor 2,Physical measures,X4194.Pulse rate,16597,0.0084647514197911,0.00267731572830849,0.00321721259230645,0.0137122902472757,0.00157157219042094
EPHA2,Ephrin type-A receptor 2,Physical measures,X4195.Pulse wave reflection index,16597,-0.0060761843071322,0.00274024881288507,-0.0114470719803869,-0.00070529663387746,0.0266103566767333
EPHA2,Ephrin type-A receptor 2,Physical measures,X4196.Pulse wave peak to peak time,16586,0.00122718491310849,0.00273353177847654,-0.00413053737270553,0.00658490719892251,0.653482616290318
EPHA2,Ephrin type-A receptor 2,Physical measures,X4198.Position of the pulse wave peak,16597,-0.00133466601847746,0.00275630801435605,-0.00673702972661532,0.0040676976896604,0.628234452422793
EPHA2,Ephrin type-A receptor 2,Physical measures,X4199.Position of pulse wave notch,16597,0.0082887288210388,0.00267277798920013,0.00305008396220654,0.0135273736798711,0.00193083346803738
EPHA2,Ephrin type-A receptor 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,16597,0.00190435083188748,0.00277628406761518,-0.00353716594063827,0.00734586760441324,0.492763592118471
EPHA2,Ephrin type-A receptor 2,Physical measures,X4269.Number of triplets attempted (left),16286,-0.0213094244081425,0.131773332411093,-0.279585155933884,0.236966307117599,0.871534094378774
EPHA2,Ephrin type-A receptor 2,Physical measures,X4270.Volume level set by participant (left),16111,0.000209422303020506,0.0427452899586633,-0.0835713460159596,0.0839901906220006,0.996090994859439
EPHA2,Ephrin type-A receptor 2,Physical measures,X4276.Number of triplets attempted (right),16288,-0.0988713752896402,0.127916774946001,-0.349588254183801,0.151845503604521,0.439571978790441
EPHA2,Ephrin type-A receptor 2,Physical measures,X4277.Volume level set by participant (right),16104,0.0161016224389961,0.0427714138964017,-0.0677303487979512,0.0999335936759434,0.706581720162644
EPHA2,Ephrin type-A receptor 2,Cognitive function,X4288.Time to answer,16634,-0.00168855048356139,0.00309755669610141,-0.00775976160792016,0.00438266064079738,0.585675999020296
EPHA2,Ephrin type-A receptor 2,Cognitive function,X4290.Duration screen displayed,16634,0.013213334824045,0.0028156058562718,0.00769474734575232,0.0187319223023378,2.7151685615001e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,X46.Hand grip strength (left),49385,-0.0423569806907548,0.0022146716043047,-0.046697737035192,-0.0380162243463176,3.04336575720523e-81
EPHA2,Ephrin type-A receptor 2,Physical measures,X47.Hand grip strength (right),49390,-0.041225489574214,0.00219530085549729,-0.0455282792509887,-0.0369226998974393,2.10784951429152e-78
EPHA2,Ephrin type-A receptor 2,Physical measures,X48.Waist circumference,49531,0.01257621,0.003433386,0.005846774,0.01930564,0.0002496182
EPHA2,Ephrin type-A receptor 2,Health and medical history,X4803.Tinnitus,16335,0.0865940566117752,0.0492097055646483,-0.00985696629493532,0.183045079518486,0.0784783254518265
EPHA2,Ephrin type-A receptor 2,Working and living environment,X4825.Noisy workplace,16539,0.06183410051672,0.0555256561564984,-0.0469961855500168,0.170664386583457,0.265461384670841
EPHA2,Ephrin type-A receptor 2,Working and living environment,X4836.Loud music exposure frequency,16442,0.0194283030747962,0.0731477844225852,-0.123941354393471,0.162797960543063,0.790547970237542
EPHA2,Ephrin type-A receptor 2,Physical measures,X49.Hip circumference,49521,0.00228172965343094,0.00275159370178046,-0.00311139400205877,0.00767485330892065,0.406973005130161
EPHA2,Ephrin type-A receptor 2,Physical measures,X50.Standing height,49478,0.0166649973284287,0.00218371627493276,0.0123849134295605,0.0209450812272969,2.36212705862322e-14
EPHA2,Ephrin type-A receptor 2,Health and medical history,X5057.Number of older siblings,14611,-0.0148097020988735,0.0455547563932367,-0.104097024629617,0.0744776204318705,0.745112527219712
EPHA2,Ephrin type-A receptor 2,Physical measures,X51.Seated height,49275,0.00567677176628945,0.00203285030964119,0.00169238515939271,0.00966115837318619,0.00523196616167525
EPHA2,Ephrin type-A receptor 2,Eye measures,X5181.Ever had eye surgery,11214,0.197918730246835,0.0998306643572009,0.0022506281067213,0.393586832386949,0.0474427360208152
EPHA2,Ephrin type-A receptor 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),11186,0.00238199050103601,0.00325162202801796,-0.00399118867387919,0.0087551696759512,0.463845530515061
EPHA2,Ephrin type-A receptor 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),11183,0.00630708219675259,0.0032702013393287,-0.000102512428331663,0.0127166768218368,0.0537993207220008
EPHA2,Ephrin type-A receptor 2,Eye measures,X5190.Duration at which refractometer first shown (right),11064,0.00352640494818726,0.00327935923053647,-0.00290113914366422,0.00995394904003873,0.282248906654939
EPHA2,Ephrin type-A receptor 2,Eye measures,X5193.Duration at which refractometer first shown (left),11060,0.00724982628562736,0.00329507268809636,0.000791483816958491,0.0137081687542962,0.0278131786989982
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5199.logMAR, initial (right)",11145,0.127805730193518,0.0547690042279522,0.0204584819067318,0.235152978480304,0.0196374678969428
EPHA2,Ephrin type-A receptor 2,Eye measures,X5200.Final number of letters displayed (right),11145,-0.338625053406469,0.321815513896606,-0.969383460643816,0.292133353830878,0.292715294922085
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5201.logMAR, final (right)",11036,0.00900623540256237,0.0033021310712382,0.0025340585029355,0.0154784123021892,0.00639364634054007
EPHA2,Ephrin type-A receptor 2,Eye measures,X5202.Number of rounds to result (right),11145,-0.00883018207612943,0.0513289588178048,-0.109434941359027,0.091774577206768,0.86341613577129
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5206.logMAR, initial (left)",11138,0.0477169067299111,0.0542029319615675,-0.0585208399147612,0.153954653374583,0.378695192548994
EPHA2,Ephrin type-A receptor 2,Eye measures,X5207.Final number of letters displayed (left),11138,0.0912942959345053,0.321266858110887,-0.538388745962833,0.720977337831844,0.776285650294892
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5208.logMAR, final (left)",11031,0.00587486694172747,0.00329781875601549,-0.000588857820062901,0.0123385917035178,0.0748681044918951
EPHA2,Ephrin type-A receptor 2,Eye measures,X5209.Number of rounds to result (left),11133,-0.0310205491041825,0.0511052710767576,-0.131186880414628,0.0691457822062625,0.54386786913864
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",10660,-0.0101295762743101,0.00325269380385199,-0.01650485612986,-0.00375429641876019,0.00184926722432952
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",10660,-0.0113078426227637,0.00324017326056632,-0.0176585822134737,-0.00495710303205368,0.000485178010628314
EPHA2,Ephrin type-A receptor 2,Eye measures,X5256.Corneal hysteresis (right),10660,0.000421545125837655,0.00328963975212728,-0.00602614878833182,0.00686923904000713,0.898038030841515
EPHA2,Ephrin type-A receptor 2,Eye measures,X5257.Corneal resistance factor (right),10660,-0.00583556179023522,0.00327287982092132,-0.012250406239241,0.000579282658770562,0.0746139381514128
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",10635,-0.0118360366431993,0.00326320251035868,-0.0182319135635023,-0.00544015972289626,0.000287939919776473
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",10635,-0.0121446472135366,0.00323954702635881,-0.0184941593851999,-0.00579513504187337,0.000178574125626063
EPHA2,Ephrin type-A receptor 2,Eye measures,X5264.Corneal hysteresis (left),10635,0.00257735503798133,0.00329794396476016,-0.00388661513294858,0.00904132520891124,0.434523787658176
EPHA2,Ephrin type-A receptor 2,Eye measures,X5265.Corneal resistance factor (left),10635,-0.00429826377639921,0.00327130598110069,-0.0107100234993565,0.00211349594655814,0.188898478534658
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11105,0.703385358168359,0.229344865561239,0.25386942166833,1.15290129466839,0.00216788119900461
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",49393,0.0478995772187004,0.00884987580125291,0.0305538206482447,0.0652453337891561,6.24544415471634e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",49393,0.057838888954541,0.00965453643306137,0.0389159975457407,0.0767617803633412,2.10186473452206e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",49393,0.0328694023907961,0.00922991223474256,0.0147787744107007,0.0509600303708915,0.000369535296898003
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",49393,-0.0133809419443939,0.00395659849756184,-0.0211358749996151,-0.00562600888917273,0.000720341107811395
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",49393,-0.00394422694565862,0.00363999569704037,-0.0110786185118577,0.00319016462054051,0.278556303522949
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",22331,-0.0316811957920728,0.00476368277932167,-0.0410180140395433,-0.0223443775446024,2.9871736722589e-11
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",22331,-0.00159890288135377,0.0129982548852617,-0.0270754824564668,0.0238776766937592,0.90210104553447
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",22331,-0.0143980757278894,0.00928480759788457,-0.0325962986197431,0.00380014716396437,0.120984557439155
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",22331,0.0070478735323452,0.00564568792676726,-0.00401767480411863,0.018113421868809,0.211910884570682
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,49526,-0.00498202149100556,0.00609044082456706,-0.016919285507157,0.00695524252514587,0.413357289592047
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,49526,0.0175027767662872,0.00783117008947709,0.00215368339091214,0.0328518701416623,0.0254208548310295
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),49526,-0.0120086633301348,0.00600958528872874,-0.0237874504960431,-0.000229876164226447,0.0456948505087852
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',49526,-0.0180428445860395,0.00989143722896907,-0.0374300615548189,0.00134437238273984,0.0681449064545799
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),49526,0.0218155366431106,0.023983686501294,-0.0251924888994256,0.0688235621856469,0.363038467448927
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),49526,0.0115994001429106,0.0166798650376808,-0.0210931353309437,0.044291935616765,0.486799585907497
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,49526,0.0112965305495304,0.0261297382198005,-0.0399177563612786,0.0625108174603394,0.665507339558367
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,49392,0.0103395946208252,0.00505527283157217,0.00043125987094378,0.0202479293707067,0.040829700183338
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,49392,0.0256127657645999,0.00862106028369637,0.00871548760855505,0.0425100439206448,0.00297020016392863
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,49392,-0.00804717243181069,0.0045333879721506,-0.0169326128572259,0.000838267993604489,0.0758891584067898
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,49392,0.0270913770688023,0.00758656411563405,0.0122217114021596,0.0419610427354451,0.000356002218980793
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,49392,0.00801997055987225,0.00754889976922051,-0.00677587298779996,0.0228158141075445,0.288058160730025
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,49392,0.0555938382860463,0.00423075402368263,0.0473015603996283,0.0638861161724642,2.2496924568034e-39
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,15416,0.0439724420401155,0.0116806725196988,0.0210783239015058,0.0668665601787251,0.000167470975489121
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,15416,0.0050456020680418,0.0100087174297435,-0.0145714840942554,0.024662688230339,0.614183742161805
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,15416,0.114266723013588,0.0138214874683501,0.0871766075756218,0.141356838451554,1.48083072561622e-16
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,15416,0.0206385601215818,0.0109943767881566,-0.000910418383205124,0.0421875386263686,0.0605106197598204
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,49314,0.00870814579601416,0.0128431616762404,-0.016464451089417,0.0338807426814454,0.497751071302239
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,49314,0.0131900262355742,0.018992215442674,-0.0240347160320667,0.0504147685032152,0.487374197975666
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,49314,0.0775389154913254,0.0335679760219448,0.0117456824883137,0.143332148494337,0.02089739216525
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,49314,-0.00677298785562716,0.0324722182851554,-0.0704185356945318,0.0568725599832775,0.83477860783486
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,49314,0.0251022559493281,0.0111880088533885,0.00317375859668671,0.0470307533019695,0.0248577392800988
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,49314,0.0367146153624904,0.0148336555414802,0.00764065050118928,0.0657885802237916,0.0133236395786178
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,49314,0.0114811275285076,0.00687137507939701,-0.0019867676271105,0.0249490226841258,0.0947550555005681
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",15984,0.10787465486682,0.0110600499211078,0.0861969570214489,0.129552352712192,2.05748341837061e-22
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",15984,0.0594758602788949,0.0119700709607572,0.0360145211958108,0.0829371993619791,6.80956137836822e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",15984,0.132348555368176,0.0161464788653118,0.100701456792165,0.163995653944187,2.65570780862475e-16
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",15984,0.00840014374490677,0.00571596147508707,-0.00280314074626389,0.0196034282360774,0.141691394929911
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",22495,0.0251013413750396,0.00556524379285358,0.0141934635410466,0.0360092192090326,6.50400833732116e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",22495,-0.0290804106678262,0.0054328848915371,-0.0397288650552389,-0.0184319562804134,8.75174645793238e-08
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",22495,0.0053462244405595,0.0049662707574645,-0.00438766624407091,0.0150801151251899,0.28171219541976
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",22496,0.0230946906244379,0.0118397156534727,-0.000111152056368673,0.0463005333052444,0.0511156342728962
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",22496,0.0650368463329165,0.00704727617123371,0.0512241850372985,0.0788495076285346,2.97584419723527e-20
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",22496,0.0161558127345218,0.0094639107103555,-0.00239345225777493,0.0347050777268186,0.0878178494939115
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,49392,-0.000969253822710269,0.0106286800724981,-0.0218014667648066,0.019862959119386,0.927340160019633
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,49392,0.0124116154239133,0.00746921692838456,-0.00222804975572045,0.027051280603547,0.0965788149434586
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,49392,0.0556638981347335,0.0206886901351373,0.0151140654698644,0.0962137307996026,0.00713589317690045
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,49392,0.00690372047918123,0.00764549398552589,-0.00808144773244951,0.021888888690812,0.366541447684082
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,49392,-0.0102090949323204,0.00873746331800982,-0.0273345230356196,0.00691633317097888,0.242639892887151
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),49392,0.0630281022694213,0.0100241773084751,0.0433807147448101,0.0826754897940326,3.25082307246108e-10
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,49392,-0.00213448100234445,0.00329535130070453,-0.00859336955172534,0.00432440754703644,0.517165925371544
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,9591,0.0755973119740653,0.0100792120580975,0.0558420563401942,0.0953525676079364,6.93237197239907e-14
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,9591,0.0776933601467241,0.0125275320062825,0.0531393974144104,0.102247322879038,5.81246540977918e-10
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,9591,-0.07003210079596,0.00889270264153812,-0.0874617979733747,-0.0526024036185452,3.77076681279887e-15
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,9591,0.0112064990559173,0.00799708016883209,-0.00446777807499365,0.0268807761868282,0.161149660705274
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,49598,0.0109400189620369,0.00385714106846477,0.00338002246784595,0.0185000154562279,0.00456576786918592
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,49598,0.0168690363075593,0.0111078537715711,-0.00490235708472004,0.0386404296998386,0.128854858903816
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,49598,0.005585417921372,0.00360314097154222,-0.00147673838285074,0.0126475742255947,0.121111304023757
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,49598,0.0174430768157537,0.00348889720364915,0.0106048382966014,0.024281315334906,5.76460464808448e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,49598,0.0339318821566148,0.00540639324724204,0.0233353513920204,0.0445284129212092,3.49693647638273e-10
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,49598,0.0319724190004103,0.00482226723500616,0.0225207752197982,0.0414240627810224,3.38745452551046e-11
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,49598,0.0194029102691856,0.0037517470474617,0.0120494860561606,0.0267563344822105,2.32873576464005e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,49598,0.128932532473466,0.0109875930615666,0.107396850072795,0.150468214874136,9.35865705400291e-32
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,34263,-0.0176678064937234,0.00372640185833297,-0.024971554136056,-0.0103640588513908,2.13255988629871e-06
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,34263,-0.0317685836587456,0.0038915953788962,-0.0393961106013821,-0.024141056716109,3.36813802773711e-16
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,34263,0.0303583287870752,0.00438635710356195,0.0217610688640938,0.0389555887100566,4.56091976888477e-12
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,34264,-0.00236604796053884,0.00601886516476857,-0.0141630236834852,0.00943092776240756,0.694244136260451
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,34264,0.0077114472682001,0.00393699704116238,-5.06693247816561e-06,0.0154279614688784,0.0501545104211173
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,49159,-0.0127432067707264,0.00386892399813229,-0.0203262978070657,-0.00516011573438711,0.000989358254172856
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,49159,-0.0173674890937048,0.00308355173878859,-0.0234112505017304,-0.0113237276856791,1.78790995267029e-08
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,49159,0.00432474783256604,0.0034185791226904,-0.00237566724790714,0.0110251629130392,0.205851611252038
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,49159,-0.0117842334713043,0.0061855997613733,-0.023908009003596,0.000339542060987347,0.0567719090412865
EPHA2,Ephrin type-A receptor 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),49193,-0.0419679940588079,0.00339932689422167,-0.0486306747714824,-0.0353053133461335,5.7706955999993e-35
EPHA2,Ephrin type-A receptor 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,49193,-0.0107896704526524,0.00531787773040631,-0.0212127108042488,-0.000366630101056047,0.0424694787684506
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),49392,-0.0227221145332673,0.00336548074227455,-0.0293184567881254,-0.0161257722784092,1.47916873754917e-11
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,49392,-0.0230179856630257,0.003983404360543,-0.03082545820969,-0.0152105131163614,7.58344951252475e-09
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,49392,0.0190360034360956,0.0059992084162178,0.00727755494030874,0.0307944519318825,0.00150920304863989
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,49392,-0.0148426868687541,0.00762399182033792,-0.0297857108366164,0.000100337099108278,0.051559666631894
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,49392,0.0577535995601336,0.00832075051154468,0.0414449285575061,0.0740622705627612,3.94368231520566e-12
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,49392,-0.0162929845489169,0.00997019635532677,-0.0358345694053573,0.0032486003075236,0.102229771244772
EPHA2,Ephrin type-A receptor 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",28066,-0.0176983133210331,0.00212398398240805,-0.0218613219265529,-0.0135353047155133,8.26520149846906e-17
EPHA2,Ephrin type-A receptor 2,Physical activities,X864.Number of days or week walked 10+ minutes,48523,-0.122891309618408,0.024904131586207,-0.171703407527373,-0.0740792117094418,8.05910891491959e-07
EPHA2,Ephrin type-A receptor 2,Physical activities,X874.Duration of walks,42044,-0.00133196318858469,0.00163327423898932,-0.00453318069700376,0.00186925431983438,0.414780960544223
EPHA2,Ephrin type-A receptor 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46914,-0.128993222618464,0.0242135004505591,-0.17645168350156,-0.0815347617353683,1.00127500532451e-07
EPHA2,Ephrin type-A receptor 2,Physical activities,X894.Duration of moderate activity,36318,0.0269339548113385,0.0297092064541504,-0.0312960898387963,0.0851639994614733,0.364631710886689
EPHA2,Ephrin type-A receptor 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,10361,-0.00718216661838421,0.00331656420138068,-0.0136826324530903,-0.00068170078367808,0.0303688017499385
EPHA2,Ephrin type-A receptor 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46828,-0.212853284188592,0.0251029108451091,-0.262054989445006,-0.163651578932179,2.33211762284004e-17
EPHA2,Ephrin type-A receptor 2,Physical activities,X914.Duration of vigorous activity,26234,0.00594373472037673,0.00196273294668067,0.00209677814488263,0.00979069129587084,0.00246176809425269
